<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003210.pub3" GROUP_ID="MUSKINJ" ID="369500080921080334" MERGED_FROM="" MODIFIED="2009-05-13 16:13:10 +0200" MODIFIED_BY="Paolo Rosati" NOTES="&lt;p&gt;Exported from Review Manager 4.2.6&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.6&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.6&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.6&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.6&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.6&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.5&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.1&lt;br&gt;Exported from Review Manager 4.2&lt;br&gt;Date last edited when imported: 01/08/2003 from Lesley&lt;br&gt;Date last edited when imported: 06/11/2004 from Rudolf&lt;br&gt;Sent back on 06/11/2004 with amended sections cleared&lt;br&gt;Sent back on 111/02/05 with amended sections cleared&lt;br&gt;Sent back on 19/05/05 with amended sections cleared&lt;/p&gt;" NOTES_MODIFIED="2009-05-13 16:13:10 +0200" NOTES_MODIFIED_BY="Paolo Rosati" REVIEW_NO="007" REVMAN_SUB_VERSION="5.0.20" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.2">
<COVER_SHEET MODIFIED="2009-05-13 16:13:10 +0200" MODIFIED_BY="Paolo Rosati">
<TITLE>Conservative treatment for closed fifth (small finger) metacarpal neck fractures</TITLE>
<CONTACT>
<PERSON ID="15117" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Rudolf</FIRST_NAME>
<MIDDLE_INITIALS>W</MIDDLE_INITIALS>
<LAST_NAME>Poolman</LAST_NAME>
<SUFFIX>MD, PhD</SUFFIX>
<POSITION/>
<EMAIL_1>poolman@trauma.nl</EMAIL_1>
<EMAIL_2>namloop@gmail.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Orthopaedic Surgery</DEPARTMENT>
<ORGANISATION>Onze Lieve Vrouwe Gasthuis</ORGANISATION>
<ADDRESS_1>Postbus 95500</ADDRESS_1>
<ADDRESS_2/>
<CITY>Amsterdam</CITY>
<ZIP>1090 HM</ZIP>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 20 599 9111</PHONE_1>
<PHONE_2/>
<FAX_1>+31 84 759 8469</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2009-05-13 16:12:24 +0200" MODIFIED_BY="Paolo Rosati">
<PERSON ID="15117" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Rudolf</FIRST_NAME>
<MIDDLE_INITIALS>W</MIDDLE_INITIALS>
<LAST_NAME>Poolman</LAST_NAME>
<SUFFIX>MD, PhD</SUFFIX>
<POSITION/>
<EMAIL_1>poolman@trauma.nl</EMAIL_1>
<EMAIL_2>namloop@gmail.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Orthopaedic Surgery</DEPARTMENT>
<ORGANISATION>Onze Lieve Vrouwe Gasthuis</ORGANISATION>
<ADDRESS_1>Postbus 95500</ADDRESS_1>
<ADDRESS_2/>
<CITY>Amsterdam</CITY>
<ZIP>1090 HM</ZIP>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 20 599 9111</PHONE_1>
<PHONE_2/>
<FAX_1>+31 84 759 8469</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15067" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>J Carel</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Goslings</LAST_NAME>
<SUFFIX>MD, PhD</SUFFIX>
<POSITION>Medical Director</POSITION>
<EMAIL_1>j.c.goslings@amc.uva.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Trauma Unit, Department of Surgery</DEPARTMENT>
<ORGANISATION>Academic Medical Centre</ORGANISATION>
<ADDRESS_1>Meibergdreef 9</ADDRESS_1>
<ADDRESS_2/>
<CITY>Amsterdam</CITY>
<ZIP>1105 AZ</ZIP>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 20 5666019</PHONE_1>
<PHONE_2/>
<FAX_1>+31 20 6914858</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="17557" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Jason</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Lee</LAST_NAME>
<SUFFIX/>
<POSITION>Consultant in Emergency Medicine</POSITION>
<EMAIL_1>docjasonlee@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Emergency Department</DEPARTMENT>
<ORGANISATION>York Hospital</ORGANISATION>
<ADDRESS_1>Wigginton Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>York</CITY>
<ZIP>YO31 8HE</ZIP>
<REGION>North Yorkshire</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15136" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Markwin</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Statius Muller</LAST_NAME>
<SUFFIX>MD, PhD</SUFFIX>
<POSITION>Resident</POSITION>
<EMAIL_1>statiusmuller@wxs.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Surgery</DEPARTMENT>
<ORGANISATION>Rivierenland Ziekenhuis</ORGANISATION>
<ADDRESS_1>Postbus 6024</ADDRESS_1>
<ADDRESS_2/>
<CITY>Tiel</CITY>
<ZIP>4000 HA</ZIP>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15137" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>E.</FIRST_NAME>
<MIDDLE_INITIALS>Ph</MIDDLE_INITIALS>
<LAST_NAME>Steller</LAST_NAME>
<SUFFIX/>
<POSITION>General Surgeon</POSITION>
<EMAIL_1>steller1@xs4all.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Surgery</DEPARTMENT>
<ORGANISATION>St Lucas Andreas Ziekenhuis</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Amsterdam</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15140" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Peter</FIRST_NAME>
<MIDDLE_INITIALS>AA</MIDDLE_INITIALS>
<LAST_NAME>Struijs</LAST_NAME>
<SUFFIX>MD, PhD</SUFFIX>
<POSITION>Orthopaedic Surgeon</POSITION>
<EMAIL_1>P.A.Struijs@amc.uva.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Orthopaedic Surgery</DEPARTMENT>
<ORGANISATION>Academic Medical Center</ORGANISATION>
<ADDRESS_1>Meibergdreef 9</ADDRESS_1>
<ADDRESS_2/>
<CITY>Amsterdam</CITY>
<ZIP>1105 AZ</ZIP>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 624769133</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-08-04 15:05:42 +0200" MODIFIED_BY="Lindsey Elstub">
<UP_TO_DATE>
<DATE DAY="4" MONTH="8" YEAR="2008"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="3" MONTH="6" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="9" MONTH="10" YEAR="2010"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2001"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2005"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2005"/>
</DATES>
<WHATS_NEW MODIFIED="2009-05-13 16:13:10 +0200" MODIFIED_BY="Paolo Rosati">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-05-13 16:13:10 +0200" MODIFIED_BY="Paolo Rosati">
<DATE DAY="13" MONTH="5" YEAR="2009"/>
<DESCRIPTION>
<P>No changes - republished to fix technical problem.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-05-13 16:12:39 +0200" MODIFIED_BY="Paolo Rosati">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-05-13 16:12:39 +0200" MODIFIED_BY="Paolo Rosati">
<DATE DAY="4" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>For the first update, published in Issue 4, 2008, the following changes were made:<BR/>(1) the search was updated to June 2008, which resulted in the identification of no new studies;<BR/>(2) the 'Synopsis' was converted to a 'Plain language summary';<BR/>(3) methodological quality assessment scores were no longer totalled;<BR/>(4) some reformatting of the review and completion of one formerly incomplete table.<BR/>
<BR/>There were no changes made to the conclusions.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-05-13 16:12:39 +0200" MODIFIED_BY="Paolo Rosati">
<DATE DAY="10" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2008-08-11 15:26:21 +0200" MODIFIED_BY="Lindsey Elstub">
<DATE DAY="16" MONTH="5" YEAR="2005"/>
<DESCRIPTION>
<P>First version of the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Academic Medical Center, Amsterdam</NAME>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>St Lucas Andreas Ziekenhuis, Amsterdam</NAME>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Ziekenhuis Hilversum, Hilversum</NAME>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-08-11 15:30:39 +0200" MODIFIED_BY="Lindsey Elstub">
<SUMMARY MODIFIED="2008-08-11 15:18:49 +0200" MODIFIED_BY="Lindsey Elstub">
<TITLE MODIFIED="2008-08-04 13:25:05 +0200" MODIFIED_BY="Lindsey Elstub">Conservative treatment for closed fifth (small finger) metacarpal neck fractures</TITLE>
<SUMMARY_BODY MODIFIED="2008-08-11 15:18:49 +0200" MODIFIED_BY="Lindsey Elstub">
<P>A closed (the overlying skin remains intact) fifth metacarpal neck fracture occurs when the bone is broken just below the knuckle of the little finger. These account for approximately one in five of all hand fractures. The typical patient is a young man who sustained this injury, which is often called a boxer's fracture, as a result of throwing a punch. Currently, there is no consensus concerning the best way to treat these fractures, which because they are common and affect a mainly working-age population have important economic consequences. Usually they are treated without surgery. Conservative or non-surgical treatment generally involves fracture reduction, where the bone fragments are put back into place, followed by immobilisation by various means (e,g, plaster cast, splint, brace or strapping of adjacent fingers) and to various extents, including none at all. If one particular treatment method could be shown to be superior to all others in terms of functional outcome or allow earlier return to work, then the economic impact of this would be considerable. By examining the evidence from randomised controlled trials, this review aimed to answer &#8220;which treatment results in the best functional outcome in adults?&#8221;. Other outcomes of interest sought included pain, time to return to work and cosmetic outcome.</P>
<P>Five small studies, which included a total of 252 patients, met the inclusion criteria. Most studies were of poor quality and the patient numbers were small and none reported on hand function. There was no evidence that any of the treatments under test was significantly superior. Based upon current evidence, no single conservative method for fracture of the neck of the fifth metacarpal can be recommended as superior to another. Recovery though was generally excellent whichever method of treatment was used.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-08-11 15:18:23 +0200" MODIFIED_BY="Lindsey Elstub">
<ABS_BACKGROUND>
<P>Subcapital fractures of the fifth metacarpal bone, meaning fractures just below the knuckle of the little finger, account for approximately 20% of all hand fractures. Currently, there is no consensus concerning the optimal management of these fractures. Traditionally, treatment consists of closed reduction and external splinting in a neutral position using plaster of Paris (POP), involving the metacarpal joint, the proximal interphalangeal joint and the carpo-metacarpal joint. An alternative treatment strategy is functional treatment using taping or bracing that does not restrict movement.<BR/>
</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To compare functional treatment with immobilization, and to compare different periods and types of immobilization, for the treatment of closed fifth metacarpal neck fractures in adults.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-08-05 17:56:54 +0200" MODIFIED_BY="Lindsey Elstub">
<P>We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialized Register (June 2008), the Cochrane Central Register of Controlled Trials (<I>The Cochrane Library</I> 2008, Issue 3), OVID OldMEDLINE (1951 to 1965), OVID MEDLINE (1966 to May Week 3 2008), EMBASE (1988 to 2008, Week 22), and reference lists of articles. No language restrictions were applied.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>All randomized and quasi-randomized controlled trials which compare functional treatment with immobilization or different types of immobilization for closed fifth metacarpal neck fractures. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two review authors assessed abstracts of all studies identified by the initial search, identified studies meeting the selection criteria, independently assessed the quality of the trial reports, and extracted and analysed the data.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-07-14 20:29:19 +0200" MODIFIED_BY="Lindsey Elstub">
<P>Five studies met the inclusion criteria including a total of 252 participants. Most studies were of poor quality. The primary outcome measure, function of the hand, was not used in any studies. There was no evidence that any of the treatment modalities was statistically significantly superior.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-08-11 15:18:23 +0200" MODIFIED_BY="Lindsey Elstub">
<P>No included studies reported our primary outcome measure of interest, validated hand function. There was heterogeneity between the studies, which were of limited quality and size. Consequently, no single non-operative treatment regimen for fracture of the neck of the fifth metacarpal can be recommended as superior to another. Further research is definitely warranted.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-08-11 15:30:39 +0200" MODIFIED_BY="Lindsey Elstub">
<BACKGROUND MODIFIED="2008-07-14 20:30:28 +0200" MODIFIED_BY="Lindsey Elstub">
<P>Fractures of the fifth (small finger) metacarpal neck are common injuries, accounting for approximately 20% of all hand fractures (<LINK REF="REF-Hunter-1970" TYPE="REFERENCE">Hunter 1970</LINK>). The fractures are usually sustained by an axial blow on the metacarpal phalangeal (MCP) joint in flexed position, hence the name 'Boxer's fracture'.</P>
<P>At the time of injury, the normal pre-existing angulation in a palmar direction of the metacarpal head increases. This is due to the force causing the fracture and the flexion forces across the metacarpal-phalangeal joint produced by the resting tension of the intrinsic and extrinsic muscles of the hand. This angulation causes a shortening of the metacarpal neck, which can result in loss of the normal prominence of the fifth knuckle. This may give rise to cosmetic complaints (<LINK REF="REF-Ali-1999" TYPE="REFERENCE">Ali 1999</LINK>).</P>
<P>At present, there is no consensus on the optimal management of these fractures. The extent of acceptable palmar angulation remains under debate; recommendations in the literature vary from 20 degrees to 70 degrees (<LINK REF="REF-Braakman-1998a" TYPE="REFERENCE">Braakman 1998a</LINK>; <LINK REF="REF-Ford-1989" TYPE="REFERENCE">Ford 1989</LINK>; <LINK REF="REF-Hansen-1998a" TYPE="REFERENCE">Hansen 1998a</LINK>; <LINK REF="STD-Konradsen-1990" TYPE="STUDY">Konradsen 1990</LINK>; <LINK REF="STD-Kuokkanen-1999" TYPE="STUDY">Kuokkanen 1999</LINK>; <LINK REF="STD-McMahon-1994" TYPE="STUDY">McMahon 1994</LINK>; <LINK REF="STD-Sorensen-1993" TYPE="STUDY">Sorensen 1993</LINK>; <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>;<LINK REF="REF-Theeuwen-1991" TYPE="REFERENCE">Theeuwen 1991</LINK>). A biomechanical study concluded that 30 degrees is the upper limit for acceptable final angulation (<LINK REF="REF-Ali-1999" TYPE="REFERENCE">Ali 1999</LINK>). Although investigations have shown that palmar angulation of the neck of the fifth metacarpal rarely gives rise to any functional disability, no clinical study has provided a conclusive answer to the question of how much angulation is acceptable in terms of functional recovery or residual symptoms.</P>
<P>Another undetermined variable is the optimal length of treatment by cast or bandage. In different studies this period varies from one week of immobilization followed by functional treatment, to longer periods of pure immobilization.</P>
<P>Traditionally, treatment of this fracture consists of closed reduction and external splinting in a neutral position using plaster of Paris. A cast is applied as an ulnar gutter cast in which the MCP and PIP (proximal interphalangeal) joints are immobilized, as well as the wrist (<LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>). An alternative is functional treatment, either by casting or taping. Functional casting allows the wrist and the finger joints free range of motion and is applied circularly around the metacarpals (<LINK REF="STD-Hansen-1998" TYPE="STUDY">Hansen 1998</LINK>). Functional taping techniques may be used. Typically, tape is applied to splint the fourth finger against the fifth, thus preventing rotational deformity; a broad circular strap supports the fingers (<LINK REF="REF-Braakman-1998a" TYPE="REFERENCE">Braakman 1998a</LINK>); a compression glove is placed over the entire hand, which does not limit the range of movement in any joint (<LINK REF="STD-McMahon-1994" TYPE="STUDY">McMahon 1994</LINK>). A third alternative is that patients may be given full dynamic treatment (no immobilization) and are advised to use the hand as normally as possible. In this case, no support is used.</P>
<P>Delayed union, or nonunion, is uncommon. Therefore functional treatment is advocated by some groups. Published studies conducted in the last 10 years have shown acceptable results for both immobilization and functional treatment. The purpose of this systematic review is to identify evidence for the optimal conservative treatment for fifth metacarpal neck fractures. Another review looking at randomized controlled trials of operative treatment options is planned by the authors.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To compare functional treatment with immobilization, and to compare differing periods and types of immobilization for the treatment of closed fifth metacarpal neck fractures in adults.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-08-11 15:27:07 +0200" MODIFIED_BY="Lindsey Elstub">
<SELECTION_CRITERIA MODIFIED="2008-08-11 15:18:50 +0200" MODIFIED_BY="Lindsey Elstub">
<CRIT_STUDIES MODIFIED="2008-08-11 15:18:50 +0200" MODIFIED_BY="Lindsey Elstub">
<P>All randomised and quasi-randomised (methods of allocating participants to a treatment which are not strictly random: e.g. date of birth, hospital record number or alternation) controlled trials which compare functional treatment with immobilization for closed fifth metacarpal neck fractures.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>In our protocol, we planned to focus on adults with closed fifth metacarpal neck fractures. However, for practical reasons we decided to include children and adolescents where the original studies had done so. If data were presented on different groups with this injury, e.g. sports people, we planned to analyse these groups separately.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>The interventions of interest were:<BR/>
</P>
<UL>
<LI>splinting with plaster of Paris with immobilization of both the MCP and wrist joint;</LI>
<LI>functional bracing with free movement in both the MCP and wrist joint;</LI>
<LI>functional taping with free movement in both the MCP and wrist joint;</LI>
<LI>elastic (or compression) bandage with free movement in both the MCP and wrist joint;</LI>
<LI>full dynamic treatment with no external support with free movement in both the MCP and wrist joint.</LI>
</UL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-07-10 15:14:00 +0200" MODIFIED_BY="Lindsey Elstub">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-07-10 15:13:57 +0200" MODIFIED_BY="Lindsey Elstub">
<UL>
<LI>Functional outcome (based on activities of daily living (ADL) assessments and validated hand function scores)</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-07-10 15:13:43 +0200" MODIFIED_BY="Lindsey Elstub">
<UL>
<LI>Patient satisfaction</LI>
<LI>Cosmetic appearance</LI>
<LI>Pain</LI>
<LI>Non-union (failure of fracture to unite more than six months post injury, with radiographic evidence of fracture line or pain at the fracture site)</LI>
<LI>Malunion</LI>
<LI>Rotational deformity</LI>
<LI>Fracture angulation</LI>
<LI>Range of motion: flexion and extension in MCP</LI>
<LI>Grip strength</LI>
<LI>Time to union</LI>
<LI>Re-intervention</LI>
<LI>Infection</LI>
<LI>Skin damage</LI>
<LI>Time to return to work (days off) or return to previous activity (e.g. sports)</LI>
<LI>Cost of treatment</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-08-11 15:27:07 +0200" MODIFIED_BY="Lindsey Elstub">
<ELECTRONIC_SEARCHES MODIFIED="2008-08-05 12:25:34 +0200" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialized Register (June 2008), the Cochrane Central Register of Controlled Trials (<I>The Cochrane Library</I> 2008, Issue 3), OVID OldMEDLINE (1951 to 1965), OVID MEDLINE (1966 to May Week 3 2008), EMBASE (1988 to 2008, Week 22). No language restrictions were applied.</P>
<P>In MEDLINE (OVID-WEB), the first two phases of the Cochrane optimal trial search strategy (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>) was combined with the subject specific search (<I>see</I> <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>). Search strategies for EMBASE (OVID-WEB) and <I>The Cochrane Library</I> (Wiley InterScience) are shown in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK> and <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> respectively.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2008-08-11 15:27:07 +0200" MODIFIED_BY="Lindsey Elstub">
<P>We also searched Google Scholar and reference lists of articles.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-08-11 15:18:53 +0200" MODIFIED_BY="Lindsey Elstub">
<SUBSECTION>
<HEADING LEVEL="3">Selection of studies</HEADING>
<P>Two authors (JCG and RWP) assessed abstracts of all studies identified by the initial search and excluded clearly non-relevant studies. Full copies of the reports of potentially relevant studies were independently assessed by two authors (JCG and RWP) using the above mentioned inclusion criteria. Disagreements on inclusion were resolved by discussion and, if necessary, by scrutiny by an independent third author (JBL).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of methodological quality of included studies</HEADING>
<P>In this review, risk of bias is implicitly assessed in terms of methodological quality.<BR/>
</P>
<P>The quality of the selected studies was independently assessed, without masking of the source and authorship of the trial reports, by two authors (JCG and RWP) using a quality assessment tool derived from the generic scheme formerly used by the Cochrane Bone, Joint and Muscle Trauma Group (<I>see </I>
<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). This scoring scheme considers various aspects of internal and external validity. From Issue 4, 2008, overall scores were no longer calculated. Disagreement was resolved by discussion and, if necessary, by scrutiny by an independent third author (JBL).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data analysis</HEADING>
<P>Data were extracted from all relevant studies independently by two authors. If data were incomplete or require clarification, attempts were made to contact the authors for further information. Agreement on data extraction discrepancies was reached by consensus. For each study, relative risks and 95% confidence intervals were calculated for dichotomous outcomes. We would have calculated the mean difference and 95% confidence intervals for continuous data. Where appropriate, results of comparable groups of trials were pooled using the fixed-effect model. Heterogeneity was assessed using the standard chi-squared test in conjunction with the I<SUP>2</SUP> test (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). Where there was clear heterogeneity we pooled data using the random-effects model.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Patient satisfaction</HEADING>
<P>Where satisfaction was reported in three categories as "fully satisfied", "satisfied" or "dissatisfied", the data were dichotomized by combining the "satisfied" and "dissatisfied" categories to become "not fully satisfied". If participants had any residual complaints, they were analysed in the "not fully satisfied" group. Cosmetic appearance judged by the patient was grouped in patient satisfaction as well in the same manner.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Pain</HEADING>
<P>Where pain was reported in three categories, "no pain", "moderate pain" or "severe pain", the data were dichotomized by combining the "moderate pain" and "severe pain" categories to become "pain". If participants had any residual complaints, they were analysed in the "pain" group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Range of motion (ROM)</HEADING>
<P>Numbers of participants with decreased ROM at three to six weeks and final follow up were extracted from tables and text where possible. If percentages were given numbers were calculated. Data were dichotomized into two groups: participants with decreased ROM and participants with full ROM.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Grip strength</HEADING>
<P>Numbers of participants with decreased grip strength at three to six weeks follow up were extracted from tables and text where possible. Data were dichotomized to participants with loss of grip strength and participants with normal grip strength.</P>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-08-11 15:30:39 +0200" MODIFIED_BY="Lindsey Elstub">
<STUDY_DESCRIPTION MODIFIED="2008-08-11 15:27:53 +0200" MODIFIED_BY="Lindsey Elstub">
<P>
<BR/>
</P>
<SEARCH_RESULTS MODIFIED="2008-08-11 15:27:53 +0200" MODIFIED_BY="Lindsey Elstub">
<P>In the first published version of this review (2004), we reported that the MEDLINE search retrieved 50 studies and the EMBASE search 76. The updated search (June 2004 to June 2008) identified a total of 117 new references, none of which were for eligible studies.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2008-08-11 15:18:57 +0200" MODIFIED_BY="Lindsey Elstub">
<P>Overall five studies met the inclusion criteria. Numbers of participants meeting the inclusion criteria, excluded before randomization, randomized in each treatment group, excluded post randomization, analysed in each treatment group and dropouts are described in <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Types of participants</HEADING>
<P>
<LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK> reported 60 participants aged 11 to 48 years with fractures of the neck of the fifth metacarpal. Gender was not described. No data were presented on different groups: e.g. sports or occupation.</P>
<P>
<LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK> described 50 consecutive participants with a fracture of the fifth metacarpal. Follow up was available for 43 men and five women aged between 14 and 44 years. No data were presented on different groups: e.g. sports or occupation.</P>
<P>
<LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK> analysed 65 participants with minimally angulated (less than 40 degrees), closed fractures of the little finger metacarpal neck with no rotational deformity or associated injury. No data were recorded regarding age and gender of the participants.</P>
<P>
<LINK REF="STD-Kuokkanen-1999" TYPE="STUDY">Kuokkanen 1999</LINK> included 29 participants (26 men and three women) with subcapital fractures of the fifth metacarpal bone. Participants with fractures angulated more than 70 degrees, fractures with pronounced deviation or rotation deformity and open fractures were excluded. Median age was 29 years (range 11 to 68).</P>
<P>
<LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK> studied 40 participants (38 men and two women) with a mean age of 29 years (range 15 to 84), with fractures of the fifth metacarpal neck.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Types of interventions</HEADING>
<P>For further details, please see <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>.</P>
<P>
<LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK>: splinting with ulnar gutter splint for three weeks after attempted reduction compared to immediate mobilization in a "bulky dressing" (compression bandage).</P>
<P>
<LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK>: ulnar gutter cast with the wrist in 45 degrees dorsiflexion, the MCP joints in 90 degrees flexion and the IP joints in 0 to 10 degrees flexion compared to functional taping (also known as neighbour strapping).</P>
<P>
<LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK>: metacarpal brace compared to neighbour strapping (also known as functional taping).</P>
<P>
<LINK REF="STD-Kuokkanen-1999" TYPE="STUDY">Kuokkanen 1999</LINK>: reduction of fracture and splinting with the MCP joints in 60 degrees flexion with the splint reaching to the level of the proximal IP joint leaving the joint free for movement for four weeks compared to an elastic bandage 5 cm wide applied circumferentially and with slight compression (compression bandage) from the MCP level to 10 cm above the wrist, following which the participants were encouraged to move the fingers immediately and they removed the bandages after one week.</P>
<P>
<LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>: ulnar gutter plaster cast for a period of three weeks followed by mobilization compared to a "pressure bandage" (compression bandage) or one week and immediate mobilization within limits imposed by pain.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Types of outcome measures</HEADING>
<P>The primary outcome measure, which we had chosen a priori (functional outcome based on activities of daily living (ADL) assessments and validated hand function scores) was not described in any of the included studies.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2008-08-04 13:47:00 +0200" MODIFIED_BY="Lindsey Elstub">
<P>The 'Characteristics of excluded studies' lists 10 studies. Four excluded studies were randomized controlled trials of participants with metacarpal fractures (<LINK REF="STD-Hansen-1998" TYPE="STUDY">Hansen 1998</LINK>; <LINK REF="STD-Konradsen-1990" TYPE="STUDY">Konradsen 1990</LINK>; <LINK REF="STD-McMahon-1994" TYPE="STUDY">McMahon 1994</LINK>; <LINK REF="STD-Sorensen-1993" TYPE="STUDY">Sorensen 1993</LINK>), but analysis was not possible as data were not presented separately for fractures of the fifth metacarpal.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-08-11 15:30:39 +0200" MODIFIED_BY="Lindsey Elstub">
<P>The quality assessment scores for the individual studies are presented in <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>. We include here a summary for the individual items.<BR/>
</P>
<P>A. Concealment of allocation<BR/>Three studies used sealed envelopes for concealment. No computer or telephone randomization was used. <LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK> used medical record numbers for randomization.</P>
<P>B. Intention-to-treat analysis<BR/>Description of the participants excluded was provided by <LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK>, <LINK REF="STD-Kuokkanen-1999" TYPE="STUDY">Kuokkanen 1999</LINK> and <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>.</P>
<P>C. Blinding outcome assessors<BR/>Only <LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK> and <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK> blinded the outcome assessors.</P>
<P>D. Comparability of treatment groups at entry<BR/>Comparability was poorly described in most studies. <LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK>, <LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK>, <LINK REF="STD-Kuokkanen-1999" TYPE="STUDY">Kuokkanen 1999</LINK> and <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK> mentioned participants demography but no adjustment was made.</P>
<P>E. Blinding of treatment providers<BR/>Blinding of treatment providers was impossible in these studies..</P>
<P>F. Care programmes, other than trial options, identical<BR/>In all studies describing the care programmes, identical programmes were used. In studies which did not describe care programmes other than the intervention, this item was scored as unknown.</P>
<P>G. Inclusion and exclusion criteria clearly defined<BR/>Inclusion criteria were described in all studies but <LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK>. Exclusion criteria were described in <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>.</P>
<P>H. Interventions clearly defined<BR/>All studies used a clearly defined and standardized intervention protocol.</P>
<P>I. Outcome measures clearly defined<BR/>All studies clearly described the outcome measures used.</P>
<P>J. Diagnostic tests<BR/>None of the studies used a validated patient outcome score. Plain radiographs were used in most studies to determine fracture angulation. <LINK REF="REF-Leung-2002" TYPE="REFERENCE">Leung 2002</LINK> clearly described that the measurement of fracture angulation on plain radiographs of small finger metacarpal neck fractures seems to be subject to a high degree of inter- and intraobserver variability.</P>
<P>K. Follow-up period<BR/>Only <LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK> followed the participants for a sufficient period. Most studies limited the follow-up period to three months. <LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK> limited the follow-up period to three weeks.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-08-11 15:19:24 +0200" MODIFIED_BY="Lindsey Elstub">
<P>A total of 252 participants were included in the five included studies. Of these participants, 117 were available for analysis in the treatment group and 120 participants were available for analysis in the control group (<I>see </I>
<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK> and <LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK> show all available outcome measures and results for the included studies.</P>
<SUBSECTION>
<HEADING LEVEL="3">Primary outcome measure</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Functional outcome (based on activities of daily living (ADL) assessments and validated hand function scores)</HEADING>
<P>None of the included studies used functional outcome assessments and validated hand function scores.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Patient satisfaction (<I>see</I> Table 4 and Analyses 1.1, 2.1, 3.1 and 4.1)</HEADING>
<P>
<LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK> described this outcome measure in terms of cosmetic satisfaction. <LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK> described patient satisfaction as participants with residual symptoms consisting of loss of power-grip, and pulling and torque strengths, as well as pain, stiffness, intolerance to change in temperature and a non-aesthetic appearance. <LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK> described patient satisfaction in three categories: fully satisfied, satisfied and dissatisfied. <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK> found that 60% of the participants were fully satisfied at six weeks follow up and 80% at 12 weeks follow up in both the cast and the bandage group.</P>
<P>Pooling of data was possible after dichotomizing in the following three studies (<LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK>; <LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK>; <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>). The pooling in analyses 2.1 and 4.1 is exploratory only.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cosmetic appearance (<I>see</I> Table 4 and Analyses 2.2, 3.2 and 4.2)</HEADING>
<P>
<LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK> did not define satisfaction with cosmetic appearance, but all participants were satisfied in the mobilized group and 20 out of 21 in the cast group. In <LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK> participants in neither group complained of a short metacarpal compared to the other side, but one patient in each group expressed concern at the lump at the fracture site.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Pain (<I>see</I> Table 4 and Analyses 02.03 and 04.03)</HEADING>
<P>In <LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK>, none of the participants had pain at three months follow up in either group. Participants treated with a brace in <LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK> complained of less pain at three weeks follow up. A three point scale was used. <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK> reported three pain groups: no pain, moderate pain and severe pain. At six weeks follow up 87% of the participants in the cast group had no pain and 13% had moderate pain. In the bandage group 70% had no pain and 30% had moderate pain at six weeks. By 12 weeks 93% had no pain and 7% had moderate pain in the cast group, while 95% had no pain and 5% had moderate pain in the bandage group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Fracture angulation (<I>see</I> Table 4)</HEADING>
<P>From the table in the abstract of <LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK> we extracted the following data, assuming that "Rx" means treatment, or reduction.<BR/>
</P>
<UL>
<LI>Dorsal angulation prior to treatment: mobilization group 41º (range 15º to 80º); immobilization group 38º (range 15º to 70º).</LI>
<LI>Dorsal angulation after treatment: mobilization group 41º (range 15º to 80º); immobilization group 27º (range 5º to 45º).</LI>
<LI>Ulnar angulation prior to treatment: mobilization group 18º (range 0º to 40º); immobilization group 15º (range 0º to 40º).</LI>
<LI>Ulnar angulation after treatment: mobilization group 18º (range 0º to 40º); immobilization group: 1º (range 0º to 10º)</LI>
</UL>
<P>
<LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK> did not find a relation between functional recovery or existence of residual symptoms and the initial fracture angulation. In <LINK REF="STD-Kuokkanen-1999" TYPE="STUDY">Kuokkanen 1999</LINK> the median primary angulation of the fracture was higher in the functional group than in the repositioned and splinted group. The angulation of the fracture remained at practically the same level compared with the primary angulation in both groups. In <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>, the fracture of the participants with a good ROM had a mean angulation of 39º (range 15º to 70º), while the participants with a moderate ROM had a mean fracture angulation of 37.5º (range 35º to 40º). The fracture of the participants whose satisfaction was good had a mean angulation of 43º (range 15º to 70º), while the participants whose satisfaction was moderate had a mean fracture angulation of 38º (range 30º to 55º). This was not described for each treatment group separately.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Range of motion (ROM) in MCP joint (<I>see</I> Table 5 and Analyses 1.2, 2.4 and 4.4)</HEADING>
<P>We were able to pool the data for<I> </I>
<LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK> and <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK> at three to six weeks follow up.<I>
<BR/>
</I>Participants with a decreased ROM were pooled for<I> </I>
<LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK>
<I>, </I>
<LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK> and<I> </I>
<LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>
<I> </I>at final follow up.<BR/>
<I>
<BR/>
</I>
<LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK> described ROM in term of extensor lag at three months follow up. In the mobilized group two participants had an extensor lag of five degrees, as had two participants in the cast group. <LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK> showed a significant difference in extension deficit after one week (P = 0.0002) At one week follow up an extension deficit of up to 30 degrees was seen in 76% of the participants treated in a cast. Likewise a flexion deficit was seen in 44% in this group. At one week follow up an extension deficit did not exceed 12 degrees in 26% of the functionally taped participants. A flexion deficit at one week was seen in 8% of this group. Only the extension deficit was significantly different after four weeks (P = 0.009). Normal mobility was restored in all participants treated by tape. In the cast group, however, the mobility was still limited in 44% after four weeks and in 8% after three months.</P>
<P>
<LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK> showed that participants treated with a brace had a slightly better ROM than the participants in the neighbour strapping group.</P>
<P>In <LINK REF="STD-Kuokkanen-1999" TYPE="STUDY">Kuokkanen 1999</LINK>, the ROM of MCP joint was higher in the functional group at four weeks, but there was no difference at three months.</P>
<P>In <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>, full range of motion was achieved in 67% of the participants in the cast group at six weeks, and in 93% at 12 weeks. In the bandage group 70% had reached full ROM at six weeks and 95% at 12 weeks.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Grip strength (<I>see</I> Table 5 and Analyses 1.3 and 4.5)</HEADING>
<P>
<LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK> utilized the Jamar dynamometer for recording grip strength of both hands. Grip strength at six weeks follow up was 91% of normal in the mobilization group (24 participants tested) and 69% of normal in the cast group (17 participants tested). At three months it was 98% of normal in the mobilized group (22 participants tested) and 99% of normal in the cast group (13 participants tested).</P>
<P>
<LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK> showed restoration of pulling strength was significantly better in the tape group after one and four weeks (P &lt; 0.001). The 50% recovery limit of power-grip and pulling strength was reached within four weeks in every patient of the tape group, compared with 52% of the participants in a cast. The tape group also showed better performance after three months. After one week and four weeks all torque strengths were significantly better in the tape group (P &lt; 0.01) with the exception of the one week pronation strength. Full functional recovery took place in all but one patient treated in a cast, in whom severe loss of power-grip, pulling strength and moderate loss of torque strength persisted. No obvious explanation could be found for the poor outcome in this patient.</P>
<P>In <LINK REF="STD-Kuokkanen-1999" TYPE="STUDY">Kuokkanen 1999</LINK>,<I> </I>the grip force of the affected hand was considerably better in the functional group at four weeks and still slightly better at three months.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Skin damage (<I>see</I> Table 5 and Analysis 3.3)</HEADING>
<P>In <LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK>, one patient complained that the brace rubbed on the ulnar border of his hand, though this did not cause any significant damage. <LINK REF="STD-Kuokkanen-1999" TYPE="STUDY">Kuokkanen 1999</LINK> found no skin damage in all participants.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Time to return to work or previous activity (<I>see</I> Table 5 and Analyses 02.05, 03.04 and 04.06)</HEADING>
<P>In <LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK>, all participants returned to their pre injury status. Thirty-four out of 37 participants treated with a brace and eight out of 28 participants treated by neighbour strapping in <LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK> had returned to work by three weeks. No data were described for working status at final follow up. At six weeks two participants in <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK> had not returned to their work or hobby, but all had by 12 weeks.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Other secondary outcome measures</HEADING>
<P>The following outcome measures were not described in any included trials.<BR/>
</P>
<UL>
<LI>Non-union</LI>
<LI>Malunion</LI>
<LI>Rotational deformity</LI>
<LI>Time to union</LI>
<LI>Re-intervention</LI>
<LI>Infection</LI>
<LI>Cost of treatment</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="4">Summary of results</HEADING>
<P>There was no statistically significant difference in range of motion between any functional treatment (functional taping or compression bandage) and immobilization (plaster cast with immobilization of the MCP and wrist joints) at any point in time (one week, three to six weeks or three to six months follow up) (<LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK>; <LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK>; <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>). The random-effects model was used to pool data as there was substantial heterogeneity at three to six weeks follow up (I<SUP>2</SUP> = 82.7%). Although we cannot determine the source (or sources) of this heterogeneity, itmay reflect, amoungst other possibilities, differences in treatment interventions (tape versus compression bandage), in study populations, or in the care programs other than the trial options.</P>
<P>
<LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK>, <LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK> and <LINK REF="STD-Kuokkanen-1999" TYPE="STUDY">Kuokkanen 1999</LINK> all reported significantly reduced grip strength at three to 6 weeks in participants immobilized in plaster of Paris (POP) splints compared to participants treated with mobilization in a bulky dressing (compression bandage), functional taping, and circular elastic bandage (compression bandage) respectively. These data could not be pooled since no standard deviations were reported and <LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK> reported the results in a graph.</P>
<P>Since none of the studies presented data on different patient groups with fracture of the neck of the fifth metacarpal, e.g. sports people, these groups could not be analysed separately.</P>
<P>
<LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK> was contacted to provide extra information, but was not able to provide any. We were unable to make contact with the authors of the other trials, with the exception of Statius Muller 2003.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-08-11 15:19:25 +0200" MODIFIED_BY="Lindsey Elstub">
<P>The objective of this Cochrane review was to compare functional treatment with immobilization, and to compare different periods and types of immobilization, for the treatment of closed fifth metacarpal neck fractures in adults. The results are disappointing. Our <I>a priori </I>primary outcome measure, validated hand function, was not reported in any study. The small number of eligible studies and variation in outcome measures between studies meant that pooling of data was only feasible for a minority of secondary outcome measures. We also need to note that, although range of movement sounds like a validated and reproducible measure, it is not so.</P>
<P>Researchers measuring true fracture angulation have compared radiographs of the contralateral (uninjured) hand (<LINK REF="REF-Abdon-1984" TYPE="REFERENCE">Abdon 1984</LINK>) or subtracted a 'normal' angulation value (<LINK REF="REF-Ford-1989" TYPE="REFERENCE">Ford 1989</LINK>), most frequently quoted as 15 degrees. One problem with this approach is that the contralateral fifth metacarpal has not infrequently been fractured previously (<LINK REF="REF-Greer-1999" TYPE="REFERENCE">Greer 1999</LINK>). The most valid reference value appears to be that derived by <LINK REF="REF-Braakman-1996" TYPE="REFERENCE">Braakman 1996</LINK>, who measured the metacarpal head/neck/shaft angle of fifth metacarpals in 225 cadaver hands on lateral and 30 oblique radiographic views. The subcapital-axis angulation (the angle measured most commonly by clinicians) was 14.6 degrees in the lateral view and 11 degrees in the oblique view, with a capital-axis angle of 26 degrees. Age, gender and hand dominance did not affect the angle measured. It can be seen that there is 15 degree difference as to what constitutes normal angulation of the fifth metacarpal neck, dependent on which axis is chosen and on which radiographic view it is measured. To complicate matters further, <LINK REF="REF-Leung-2002" TYPE="REFERENCE">Leung 2002</LINK> demonstrated poor intra- and inter-observer agreement on measured angulation by hand surgeons using agreed landmarks on plain radiographs.</P>
<P>Particularly disappointing were the paucity of patient-related quality of life data using validated instruments, and the quality of data on outcomes of personal and social importance to the person with the fracture. Of the included studies, only <LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK> reported a case of skin damage, in a patient whose metacarpal brace rubbed on the ulnar border of his hand. Skin necrosis from metacarpal braces has been documented elsewhere (<LINK REF="REF-Breddam-1995" TYPE="REFERENCE">Breddam 1995</LINK>; <LINK REF="REF-Geiger-1989" TYPE="REFERENCE">Geiger 1989</LINK>; <LINK REF="REF-Harvie-1990" TYPE="REFERENCE">Harvie 1990</LINK>; <LINK REF="REF-Ros-1996" TYPE="REFERENCE">Ros 1996</LINK>). Not all the studies considered pain to be an important outcome measure. None documented the type or amount of analgesia taken. Furthermore, assessing pain at week six or 12 when the fracture has healed does not appear to be a particularly useful outcome measure. Although average pain was documented, pain in the first week and the number of times the injured area was unintentionally knocked, with resultant severe pain was not. Intuitively, this may be the main benefit of rigid support.</P>
<P>
<LINK REF="STD-Anand-1999" TYPE="STUDY">Anand 1999</LINK> and <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK> noted that all participants had returned to work at three months but did not record a mean time to return, nor describe the occupational groups. <LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK>, who found that 34 of 37 participants treated with a metacarpal brace had returned to work by three weeks compared to only 8 of 28 participants treated with neighbour strapping, failed to describe patient occupations.</P>
<P>No included study noted non-union, malunion or rotational deformity. It is known that non-union is rare, probably due to the impacted nature of the fracture. Only <LINK REF="STD-Kuokkanen-1999" TYPE="STUDY">Kuokkanen 1999</LINK> documented time to union.</P>
<P>Some methodological limitations of the included studies warrant mention. Notably, the CONSORT guideline for publishing of RCTs was not followed by any author. Few studies described treatment or control groups in detail and most employed the sealed envelope method of allocation concealment, which is considered sub-optimal. Blinding of treatment providers was accepted to be impossible, but blinding of outcome assessors, which was possible, was only performed by <LINK REF="STD-Kuokkanen-1999" TYPE="STUDY">Kuokkanen 1999</LINK> and <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>. No study clearly described the number or reason for patient exclusion prior to randomization, and follow up proved a major handicap in three included studies (<LINK REF="STD-Braakman-1998b" TYPE="STUDY">Braakman 1998b</LINK>; <LINK REF="STD-Harding-2001" TYPE="STUDY">Harding 2001</LINK>; <LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>). Patients with Boxer's fractures are known for poor compliance with follow up arrangements (<LINK REF="REF-Hall-1987" TYPE="REFERENCE">Hall 1987</LINK>). However, the data should be subject to intention to treat analysis. Of the 163 participants in the three studies mentioned, 15 participants (9%) were lost to follow up and not analysed in the treatment group assigned. Sensitivity analysis of these studies would not have allowed conclusions of particular treatment benefits to have been drawn.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-08-07 13:59:43 +0200" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE>
<P>This review included no study that documented our primary outcome measure of interest, validated hand function. Therefore, no single treatment regimen can be recommended for all participants. However, certain interventions may offer advantages in outcome measures such as pain reduction or early return to work. 'One size may not fit all'. The informed patient should decide if their personal priority is maximum pain reduction, earliest return to work or other outcome, and subsequently choose the intervention most likely to confer that benefit.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-08-07 13:59:43 +0200" MODIFIED_BY="[Empty name]">
<P>Fracture of the fifth metacarpal neck remains an exceedingly common injury with no consensus on optimum management. A multi-centre randomized controlled trial of multiple interventions is warranted. Large patient numbers will be needed to identify real differences between treatment regimes with respect to the incidence of uncommon complications such as non union and clinical rotation. Both intermediate-term and long-term (12 to 24 months) follow up would be preferable. Outcome measures should include validated hand function scoring, daily pain scoring on validated scales, mean time of return to work, incidence of complications and the cost of each treatment regime. Both direct and indirect costs should be studied to be able to draw definitive conclusions on cost effectiveness of each intervention. Analgesia taken and occupational categories should be documented. Outcome assessors should be blinded to the treatment provided, and agreement on landmarks and radiographic views used to measure fracture angulation should be agreed <I>a priori</I>.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-08-11 15:19:25 +0200" MODIFIED_BY="Lindsey Elstub">
<P>We thank Prof William Gillespie, Prof Rajan Madhok, Dr Janet Wale, Prof Peter Herbison, Ms Leeann Morton, Mr Geoffrey Hooper, Dr Vicki Livingstone, Mr Piet de Boer, and Mrs Lesley Gillespie for helpful comments on the protocol and review. We are grateful to Zimmer Inc, Netherlands for the loan of a laptop to assist with this and other research projects.</P>
<P>We thank Dr Joanne Elliott, Mrs Lindsey Elstub and Dr Helen Handoll for their help with the first update of the review</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>Two authors, RW Poolman and M Statius Muller, were investigators for one included study (<LINK REF="STD-Statius-Muller-2003" TYPE="STUDY">Statius Muller 2003</LINK>). Investigators did not carry out quality assessment on their own study. No other conflicts are declared.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>Rudolf Poolman is the guarantor of the review.<BR/>Conceiving the review: Poolman, Steller, Statius Muller. <BR/>Designing the review: Poolman.<BR/>Coordinating the review: Poolman.<BR/>Data collection for the review: Poolman, Goslings, Lee.<BR/>Screening search results: Poolman.<BR/>Organising retrieval of papers: Poolman.<BR/>Screening retrieved papers against inclusion criteria: Poolman, Goslings, Lee.<BR/>Appraising quality of papers: Poolman, Goslings, Lee.<BR/>Abstracting data from papers: Poolman, Lee.<BR/>Writing to authors of papers for additional information: Poolman.<BR/>Obtaining and screening data on unpublished studies: Poolman.<BR/>Entering data into RevMan: Poolman, Struijs.<BR/>Analysis of data: Struijs, Poolman.<BR/>Interpretation of data: Poolman, Struijs, Lee.<BR/>Providing a methodological perspective: Struijs.<BR/>Providing a clinical perspective: Steller, Goslings, Poolman.<BR/>Providing a policy perspective: Steller, Goslings, Poolman.<BR/>Writing the review: Poolman, Lee, Struijs, Goslings, Statius Muller, Steller.<BR/>Providing general advice on the review: Steller, Goslings.<BR/>Performing previous work that was the foundation of current study: Statius Muller, Poolman, Steller.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-08-11 15:31:44 +0200" MODIFIED_BY="Lindsey Elstub">
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="MIX" ID="STD-Anand-1999" NAME="Anand 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Anand N, Tannoury TY, Mey S, Weinstein RN</AU>
<TI>Boxer's fracture: a prospective randomized study comparing immediate mobilization to immobilization [abstract]</TI>
<SO>American Academy of Orthopaedic Surgeons Annual Meeting; 1999 Feb 4-8; Anaheim (CA)</SO>
<YR>http://www.aaos.org/wordhtml/anmeet99/sciprog/010.htm (accessed 27/06/02)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Braakman-1998b" NAME="Braakman 1998b" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;Braakman M, Oderwald EE, Haentjens MH. Functional taping of fractures of the 5th metacarpal results in a quicker recovery. Injury 1998; 29(1):5-9.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Braakman M, Oderwald EE, Haentjens MH</AU>
<TI>Functional taping of fractures of the 5th metacarpal results in a quicker recovery</TI>
<SO>Injury</SO>
<YR>1998</YR>
<VL>29</VL>
<NO>1</NO>
<PG>5-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Braakman M, Oderwald EE, Haentjens MHHJ. More rapid healing of fractures of the 5th metacarpal bone due to functional taping [Abstract]. Acta Orthopaedica Scandinavica - Supplementum 1997;274:26.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Braakman M, Oderwald EE, Haentjens MHHJ</AU>
<TI>More rapid healing of fractures of the 5th metacarpal bone due to functional taping [abstract]</TI>
<SO>Acta Orthopaedica Scandinavica - Supplementum</SO>
<YR>1997</YR>
<VL>274</VL>
<PG>26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Braakman M, Oderwald EE</AU>
<TI>Faster recovery of metacarpal 5-fractures using functional taping [abstract]</TI>
<SO>Nederlands Tijdschrift voor Orthopaedie</SO>
<YR>1997</YR>
<VL>4</VL>
<PG>24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harding-2001" NAME="Harding 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;Harding IJ, Parry D, Barrington RL. The use of a moulded metacarpal brace versus neighbour strapping for fractures of the little finger metacarpal neck. J Hand Surg [Br] 2001; 26(3):261-263.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harding IJ, Parry D, Barrington RL</AU>
<TI>The use of a moulded metacarpal brace versus neighbour strapping for fractures of the little finger metacarpal neck</TI>
<SO>Journal of Hand Surgery - British Volume</SO>
<YR>2001</YR>
<VL>26</VL>
<NO>3</NO>
<PG>261-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuokkanen-1999" NAME="Kuokkanen 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;Kuokkanen HO, Mulari-Keranen SK, Niskanen RO, Haapala JK, Korkala OL. Treatment of subcapital fractures of the fifth metacarpal bone: A prospective randomised comparison between functional treatment and reposition and splinting. Scandinavian Journal of Plastic &amp;amp; Reconstructive Surgery &amp;amp; Hand Surgery 1999;33(3):315-317.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuokkanen HO, Mulari-Keranen SK, Niskanen RO, Haapala JK, Korkala OL</AU>
<TI>Treatment of subcapital fractures of the fifth metacarpal bone: A prospective randomised comparison between functional treatment and reposition and splinting</TI>
<SO>Scandinavian Journal of Plastic &amp; Reconstructive Surgery &amp; Hand Surgery</SO>
<YR>1999</YR>
<VL>33</VL>
<NO>3</NO>
<PG>315-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Statius-Muller-2003" NAME="Statius Muller 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;The boxers' fracture: a prospective randomised comparison between functional and immobilization treatment (abstract)&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Statius Muller MG, Poolman RW, van Hoogstraten MJ, Stellar EP</AU>
<TI>The boxers' fracture: a prospective randomised comparison between functional and immobilization treatment [abstract]</TI>
<SO>Dutch Orthopaedic Society; 2003 January 9-10; Nijmegen (Netherlands) http://home.pi.se/actaorthopscand/Pages/framabst.html (accessed 07/04/03)</SO>
<YR>(accessed 07 April 2003)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Statius Muller MG, Poolman RW, van Hoogstraten MJ, Steller EP</AU>
<TI>Immediate mobilization gives good results in boxer's fractures with volar angulation up to 70 degrees: a prospective randomized trial comparing immediate mobilization with cast immobilization</TI>
<SO>Archives of Orthopaedic and Trauma Surgery</SO>
<YR>2003</YR>
<VL>123</VL>
<NO>10</NO>
<PG>534-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="PMID: 14639483 [PubMed - indexed for MEDLINE]"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Cohen-2001" NAME="Cohen 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cohen AP, Shaw DL</AU>
<TI>Focused rigidity casting: a prospective randomised study</TI>
<SO>Journal of the Royal College of Surgeons of Edinburgh</SO>
<YR>2001</YR>
<VL>46</VL>
<NO>5</NO>
<PG>265-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Kleuver-1996" NAME="De Kleuver 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Kleuver M, de Winters HAH</AU>
<TI>Treatment of metacarpal fractures with a functional three-point brace [abstract]</TI>
<SO>Acta Orthopaedica Scandinavica - Supplementum</SO>
<YR>1996</YR>
<VL>267</VL>
<PG>50-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Kleuver M, de Winters HAH</AU>
<TI>Treatment of metacarpal fractures with a functional three-point brace [abstract]</TI>
<SO>Nederlands voor Orthopaedie</SO>
<YR>1995</YR>
<VL>2</VL>
<PG>120</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garramone-1996" NAME="Garramone 1996" YEAR="">
<REFERENCE NOTES="&lt;p&gt;Garramone JA. A functional analysis of short arm cast vs volar splint immobilization in the treatment of small finger metacarpal neck fractures [Abstract]. Orthopaedic Transactions 1996; 20(4):910.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garramone JA</AU>
<TI>A functional analysis of short arm cast vs volar splint immobilization in the treatment of small finger metacarpal neck fractures [abstract]</TI>
<SO>Orthopaedic Transactions</SO>
<YR>1996</YR>
<VL>20</VL>
<NO>4</NO>
<PG>910</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Garramone JA. A functional analysis of short arm cast vs. volar splint immobilisation in the treatment of small finger meta-carpal neck fractures [Abstract]. Orthopaedic Transactions 1997; 21(1):320-321.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garramone JA</AU>
<TI>A functional analysis of short arm cast vs. volar splint immobilisation in the treatment of small finger meta-carpal neck fractures [abstract]</TI>
<SO>Orthopaedic Transactions</SO>
<YR>1997</YR>
<VL>21</VL>
<NO>1</NO>
<PG>320-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Garramone JA. A functional analysis of short arm cast vs. volar splint immobilisation in the treatment of small finger meta-carpal neck fractures [Abstract]. Orthopaedic Transactions 1998; 22(1):175.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garramone JA</AU>
<TI>A functional analysis of short arm cast vs. volar splint immobilisation in the treatment of small finger meta-carpal neck fractures [abstract]</TI>
<SO>Orthopaedic Transactions</SO>
<YR>1998</YR>
<VL>22</VL>
<NO>1</NO>
<PG>175</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Garramone JA. A functional analysis of short arm cast vs. volar splint immobilisation in the treatment of small finger meta-carpal neck fractures [Abstract]. Orthopaedic Transactions 1998; 22(4):1304.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garramone JA</AU>
<TI>A functional analysis of short arm cast vs. volar splint immobilisation in the treatment of small finger meta-carpal neck fractures [abstract]</TI>
<SO>Orthopaedic Transactions</SO>
<YR>1998</YR>
<VL>22</VL>
<NO>4</NO>
<PG>1304</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Garramone JA. A functional analysis of short arm cast vs. volar splint immobilization in the treatment of small finger metacarpal neck fractures [Abstract]. Orthopaedic Transactions 1996; 20(4):880.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garramone JA</AU>
<TI>A functional analysis of short arm cast vs. volar splint immobilization in the treatment of small finger metacarpal neck fractures [abstract]</TI>
<SO>Orthopaedic Transactions</SO>
<YR>1996</YR>
<VL>20</VL>
<NO>4</NO>
<PG>880</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hansen-1998" NAME="Hansen 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;Hansen PB, Hansen TB. The treatment of fractures of the ring and little metacarpal necks. A prospective randomized study of three different types of treatment. J Hand Surg [Br] 1998; 23(2):245-247.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hansen PB, Hansen TB</AU>
<TI>The treatment of fractures of the ring and little metacarpal necks. A prospective randomized study of three different types of treatment</TI>
<SO>Journal of Hand Surgery - British Volume</SO>
<YR>1998</YR>
<VL>23</VL>
<NO>2</NO>
<PG>245-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Hansen PB, Hansen TB. The treatment of subcapital fractures of the fourth and fifth metacarpals - a prospective randomised study of three different types of immobilisation [Abstract]. Acta Orthopaedica Scandinavica - Supplementum 1997; 274:31.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hansen PB, Hansen TB</AU>
<TI>The treatment of subcapital fractures of the fourth and fifth metacarpals - a prospective randomised study of three different types of immobilisation [abstract]</TI>
<SO>Acta Orthopaedica Scandinavica - Supplementum</SO>
<YR>1997</YR>
<VL>274</VL>
<PG>31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hutchison-1996" NAME="Hutchison 1996" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hutchison CR, Brown M, Regher G, Backstein D, Murnaghan J, Reznick R</AU>
<TI>Improving the technical performance of our surgical trainees [abstract]</TI>
<SO>Orthopaedic Transactions</SO>
<YR>1996</YR>
<VL>20</VL>
<NO>4</NO>
<PG>999</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Konradsen-1990" NAME="Konradsen 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Konradsen L, Nielsen PT, Albrecht Beste E. Functional treatment of metacarpal fractures 100 randomized cases with or without fixation. Acta Orthop Scand 1990;61(6):531-534.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Konradsen L, Nielsen PT, Albrecht Beste E</AU>
<TI>Functional treatment of metacarpal fractures 100 randomized cases with or without fixation</TI>
<SO>Acta Orthopaedica Scandinavica</SO>
<YR>1990</YR>
<VL>61</VL>
<NO>6</NO>
<PG>531-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McMahon-1994" NAME="McMahon 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;McMahon PJ, Woods DA, Burge PD. Initial treatment of closed metacarpal fractures. A controlled comparison of compression glove and splintage. J Hand Surg [Br] 1994;19(5):597-600.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McMahon PJ, Woods DA, Burge PD</AU>
<TI>Initial treatment of closed metacarpal fractures. A controlled comparison of compression glove and splintage</TI>
<SO>Journal of Hand Surgery - British Volume</SO>
<YR>1994</YR>
<VL>19</VL>
<NO>5</NO>
<PG>597-600</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Randall-1992" NAME="Randall 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Randall T, Poutney L, Harris BA</AU>
<TI>Effects of joint mobilization on joint stiffness and active motion of the metacarpo-phalangeal joint</TI>
<SO>Journal of Orthopaedic and Sports Physical Therapy</SO>
<YR>1992</YR>
<VL>16</VL>
<PG>30-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sorensen-1993" NAME="Sorensen 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Sorensen JS, Freund KG, Kejla G. Functional fracture bracing in metacarpal fractures: the Galveston metacarpal brace versus a plaster-of-Paris bandage in a prospective study. Journal of Hand Therapy 1993;6(4):263-265.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sorensen JS, Freund KG, Kejla G</AU>
<TI>Functional fracture bracing in metacarpal fractures: the Galveston metacarpal brace versus a plaster-of-Paris bandage in a prospective study</TI>
<SO>Journal of Hand Therapy</SO>
<YR>1993</YR>
<VL>6</VL>
<NO>4</NO>
<PG>263-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-08-11 15:31:44 +0200" MODIFIED_BY="Lindsey Elstub">
<ADDITIONAL_REFERENCES MODIFIED="2008-08-11 15:31:44 +0200" MODIFIED_BY="Lindsey Elstub">
<REFERENCE ID="REF-Abdon-1984" MODIFIED="2008-08-11 15:31:33 +0200" MODIFIED_BY="Lindsey Elstub" NAME="Abdon 1984" TYPE="JOURNAL_ARTICLE">
<AU>Abdon P, Muhlow A, Stigsson L, Thorngren KG, Werner CO, Westman L</AU>
<TI>Subcapital fractures of the fifth metacarpal bones</TI>
<SO>Archives of Orthopaedic &amp; Traumatic Surgery</SO>
<YR>1984</YR>
<VL>103</VL>
<NO>4</NO>
<PG>231-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ali-1999" NAME="Ali 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ali A, Hamman J, Mass DP</AU>
<TI>The biomechanical effects of angulated boxer's fractures</TI>
<SO>Journal of Hand Surgery - American Volume</SO>
<YR>1999</YR>
<VL>24</VL>
<NO>4</NO>
<PG>835-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Braakman-1996" NAME="Braakman 1996" TYPE="JOURNAL_ARTICLE">
<AU>Braakman M</AU>
<TI>Normal radiographic angulation in the 4th and 5th metacarpal: a reference guide</TI>
<SO>European Journal of Radiology</SO>
<YR>1996</YR>
<VL>22</VL>
<NO>1</NO>
<PG>38-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Braakman-1998a" NAME="Braakman 1998a" TYPE="JOURNAL_ARTICLE">
<AU>Braakman M, Oderwald EE, Haentjens MH</AU>
<TI>Functional taping of fractures of the 5th metacarpal results in a quicker recovery</TI>
<SO>Injury</SO>
<YR>1998</YR>
<VL>29</VL>
<NO>1</NO>
<PG>5-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Breddam-1995" MODIFIED="2008-08-11 15:31:35 +0200" MODIFIED_BY="Lindsey Elstub" NAME="Breddam 1995" TYPE="JOURNAL_ARTICLE">
<AU>Breddam M, Hansen TB</AU>
<TI>Subcapital fractures of the fourth and fifth metacarpals treated without splinting and reposition</TI>
<SO>Scandinavian Journal of Plastic &amp; Reconstructive Surgery &amp; Hand Surgery</SO>
<YR>1995</YR>
<VL>29</VL>
<NO>3</NO>
<PG>269-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ford-1989" NAME="Ford 1989" TYPE="JOURNAL_ARTICLE">
<AU>Ford DJ, Ali MS, Steel WM</AU>
<TI>Fractures of the fifth metacarpal neck: is reduction or immobilisation necessary?</TI>
<SO>Journal of Hand Surgery - British Volume</SO>
<YR>1989</YR>
<VL>14</VL>
<NO>2</NO>
<PG>165-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Geiger-1989" NAME="Geiger 1989" TYPE="JOURNAL_ARTICLE">
<AU>Geiger KR, Karpan RR</AU>
<TI>Necrosis of the skin over the metacarpal as a result of functional fracture-bracing. A report of three cases</TI>
<SO>Journal of Bone and Joint Surgery - British Volume</SO>
<YR>1989</YR>
<VL>71</VL>
<NO>8</NO>
<PG>1199-202</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Greer-1999" MODIFIED="2008-08-11 15:31:37 +0200" MODIFIED_BY="Lindsey Elstub" NAME="Greer 1999" TYPE="JOURNAL_ARTICLE">
<AU>Greer SE, Williams JM</AU>
<TI>Boxer's fracture: an indicator of intentional and recurrent injury</TI>
<SO>American Journal of Emergency Medicine</SO>
<YR>1999</YR>
<VL>17</VL>
<NO>4</NO>
<PG>357-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hall-1987" NAME="Hall 1987" TYPE="JOURNAL_ARTICLE">
<AU>Hall Jr RF</AU>
<TI>Treatment of metacarpal and phalangeal fractures in noncompliant patients</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>1987</YR>
<VL>(214)</VL>
<PG>31-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hansen-1998a" NAME="Hansen 1998a" TYPE="JOURNAL_ARTICLE">
<AU>Hansen PB, Hansen TB</AU>
<TI>The treatment of fractures of the ring and little metacarpal necks. A prospective randomized study of three different types of treatment</TI>
<SO>Journal of Hand Surgery - British Volume</SO>
<YR>1998</YR>
<VL>23</VL>
<NO>2</NO>
<PG>245-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Harvie-1990" MODIFIED="2008-08-11 15:31:41 +0200" MODIFIED_BY="Lindsey Elstub" NAME="Harvie 1990" TYPE="JOURNAL_ARTICLE">
<AU>Harvie KW</AU>
<TI>Necrosis of the skin over the metacarpal as a result of functional fracture-bracing</TI>
<SO>Journal of Bone and Joint Surgery - American Volume</SO>
<YR>1990</YR>
<VL>72</VL>
<NO>7</NO>
<PG>1114-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2006" MODIFIED="2008-08-05 12:24:35 +0200" MODIFIED_BY="[Empty name]" NAME="Higgins 2006" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Appendix 5b</TI>
<SO>www.cochrane.org/resources/handbook/hbook.htm (accessed 01 May 2007)</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hunter-1970" NAME="Hunter 1970" TYPE="JOURNAL_ARTICLE">
<AU>Hunter JM, Cowen M</AU>
<TI>Fifth metacarpal fractures in a compensation clinic population. A report on one hundred and thirty-three cases</TI>
<SO>Journal of Bone and Joint Surgery - American Volume</SO>
<YR>1970</YR>
<VL>52</VL>
<NO>6</NO>
<PG>1159-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leung-2002" MODIFIED="2008-08-11 15:31:44 +0200" MODIFIED_BY="Lindsey Elstub" NAME="Leung 2002" TYPE="JOURNAL_ARTICLE">
<AU>Leung YL, Beredjiklian PK, Monaghan BA, Bozentka DJ</AU>
<TI>Radiographic assessment of small finger metacarpal neck fractures</TI>
<SO>Journal of Hand Surgery - American Version</SO>
<YR>2002</YR>
<VL>27</VL>
<NO>3</NO>
<PG>443-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ros-1996" NAME="Ros 1996" TYPE="JOURNAL_ARTICLE">
<AU>Ros NOJ, Mora F, Canovas A</AU>
<TI>Orthopaedic functional treatment of fractures of the fifth metacarpal</TI>
<TO>Tratamiento ortopedico funcional de las fracturas del tercio distal del quinto metacarpiano</TO>
<SO>Revista de Ortopedia y Traumatologia</SO>
<YR>1996</YR>
<VL>41</VL>
<NO>1</NO>
<PG>64-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Theeuwen-1991" NAME="Theeuwen 1991" TYPE="JOURNAL_ARTICLE">
<AU>Theewen GA, Lemmens JA, van Niekerk JL</AU>
<TI>Conservative treatment of boxer's fracture: a retrospective analysis</TI>
<SO>Injury</SO>
<YR>1991</YR>
<VL>22</VL>
<NO>5</NO>
<PG>394-6</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-08-11 15:19:28 +0200" MODIFIED_BY="Lindsey Elstub">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-08-11 15:19:28 +0200" MODIFIED_BY="Lindsey Elstub" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-08-11 15:19:26 +0200" MODIFIED_BY="Lindsey Elstub" STUDY_ID="STD-Anand-1999">
<CHAR_METHODS MODIFIED="2008-08-04 13:39:18 +0200" MODIFIED_BY="Lindsey Elstub">
<P>Method of randomisation: Medical record number</P>
<P>Blinding of outcome assessors: No blinding</P>
<P>Length of follow up: Three months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-11 15:19:26 +0200" MODIFIED_BY="Lindsey Elstub">
<P>60 patients with fractures of the neck of the fifth metacarpal.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-02 16:02:30 +0200" MODIFIED_BY="[Empty name]">
<P>(1) Immediate mobilization with a bulky dressing.</P>
<P>(2) Immobilization with an ulnar gutter splint for 3 weeks and attempt to reduction.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-14 20:20:22 +0200" MODIFIED_BY="Lindsey Elstub">
<P>Angulation<BR/>Cosmetic satisfaction<BR/>Extensor lag<BR/>Pain<BR/>Return to pre-injury status<BR/>Grip strength</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Randomization based on medical record number</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-11 15:19:26 +0200" MODIFIED_BY="Lindsey Elstub" STUDY_ID="STD-Braakman-1998b">
<CHAR_METHODS MODIFIED="2008-08-04 13:39:30 +0200" MODIFIED_BY="Lindsey Elstub">
<P>Method of randomisation: No description of method, only states randomised.</P>
<P>Blinding of outcome assessors: No blinding</P>
<P>Length of follow up: Six months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-11 15:19:26 +0200" MODIFIED_BY="Lindsey Elstub">
<P>50 patients with fractures of the fifth metacarpal proximal, shaft and neck.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>(1) Immediate mobilization with a tape splinting the fourth digit against the fifth, a broad circular strap was supporting the metacarpals.</P>
<P>(2) Immobilization with a U shaped ulnar gutter splint with the wrist in 45 degrees dorsiflexion, MCP joints in 90 degrees flexion and IP joint in 0-10 flexion surrounding the fourth and fifth metacarpal for 4 weeks and attempt to reduction only in patients with rotational deformity, midshaft angulation exceeding 20 degrees, and subcapital angulation exceeding 50 degrees.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-14 20:20:28 +0200" MODIFIED_BY="Lindsey Elstub">
<P>Volar angulation<BR/>ROM<BR/>Grip strength</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-11 15:19:27 +0200" MODIFIED_BY="Lindsey Elstub" STUDY_ID="STD-Harding-2001">
<CHAR_METHODS MODIFIED="2008-08-04 13:39:35 +0200" MODIFIED_BY="Lindsey Elstub">
<P>Method of randomisation: Sealed envelopes</P>
<P>Blinding of outcome assessors: Blinded</P>
<P>Length of follow up: Three weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-11 15:19:27 +0200" MODIFIED_BY="Lindsey Elstub">
<P>73 patients with minimally angulated (&lt; 40 degrees) closed fractures of the little finger metacarpal neck with no rotational deformity or associated injury.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>(1) Neighbour strapping with early active mobilization of the MCP and IP joints for 3 weeks. </P>
<P>(2) Metacarpal brace heat moulded to the contours of the patient's hand while the metacarpal head was supported and held in place by a bandage. Early active mobilization of the MCP and IP joints for 3 weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-14 20:20:34 +0200" MODIFIED_BY="Lindsey Elstub">
<P>Pain 0-3 scale<BR/>Malunion<BR/>Volar angulation<BR/>Rotational deformity<BR/>ROM<BR/>Patient satisfaction<BR/>Skin damage<BR/>Time to work<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-11 15:19:27 +0200" MODIFIED_BY="Lindsey Elstub" STUDY_ID="STD-Kuokkanen-1999">
<CHAR_METHODS MODIFIED="2008-08-11 14:43:28 +0200" MODIFIED_BY="[Empty name]">
<P>Method of randomisation: Sealed envelopes</P>
<P>Blinding of outcome assessors: No blinding</P>
<P>Length of follow up: Three months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-11 15:19:27 +0200" MODIFIED_BY="Lindsey Elstub">
<P>29 patients with closed subcapital fractures of the fifth metacarpal bone not exceeding more than 70 degrees of angulation or deviation or rotation deformity.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>(1) Immediate mobilization by an elastic bandage 5 cm wide applied circumferentially and with slight compression from the MCP level to 10 cm above the wrist for one week.</P>
<P>(2) Immobilization after reposition and splinting as described by O'Brien. MCP joint was immobilized in 60 degrees flexion and the splint reached to the level of the PIP joint leaving the joint free for movement for 4 weeks.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-14 20:20:39 +0200" MODIFIED_BY="Lindsey Elstub">
<P>Non-union<BR/>Volar angulation<BR/>ROM<BR/>Grip strength<BR/>Time to union<BR/>Skin damage<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-11 15:19:28 +0200" MODIFIED_BY="Lindsey Elstub" STUDY_ID="STD-Statius-Muller-2003">
<CHAR_METHODS MODIFIED="2008-08-04 13:39:53 +0200" MODIFIED_BY="Lindsey Elstub">
<P>Method of randomisation: Sealed envelopes</P>
<P>Blinding of outcome assessors: Blinded</P>
<P>Length of follow up: Three months<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-11 15:19:28 +0200" MODIFIED_BY="Lindsey Elstub">
<P>40 patients with subcapital fractures of the fifth metacarpal, except those angulated more than 70 degrees, older than 3 days, re-fractures, pathologic fractures and fractures with a rotation deformity.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>(1) Immediate mobilization with a pressure bandage applied to splint the fourth and fifth metacarpals together with a broad circular bandage from the metacarpal level to 10 cm above the wrist. The patients were encouraged to move the fingers immediately and they removed the bandages after one week. </P>
<P>(2) Immobilization in an ulnar gutter cast applied with the wrist in 45 dorsiflexion and the metacarpal joints in 90 flexion. The cast was U-shaped and surrounded the fourth and fifth metacarpals for 3 weeks, no reposition. </P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-07-14 20:20:44 +0200" MODIFIED_BY="Lindsey Elstub">
<P>Pain<BR/>ROM<BR/>Patient satisfaction<BR/>Volar angulation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-04 13:39:47 +0200" MODIFIED_BY="Lindsey Elstub"/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>IP: inter-phalangeal<BR/>MCP: metacarpo-phalangeal<BR/>ROM: range of motion<BR/>VAS: visual analogue score<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-07-14 22:54:48 +0200" MODIFIED_BY="Lindsey Elstub" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Cohen-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. Fractures of the base of the fifth metacarpal and distal radius fractures. No separate data analysis was possible for the fifth metacarpal fractures.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-De-Kleuver-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. In this abstract of a Dutch orthopaedic meeting insufficient data were given to be interpreted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Garramone-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. In this abstract a short arm cast was compared to volar splint. Insufficient data were given on the exact treatment modalities. Unclear if free motion in MCP was possible in one of the treatment groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hansen-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. The type of participants did not meet the inclusion criteria. Described fourth and fifth metacarpal fractures. No separate data analysis was possible for the fifth metacarpal fractures.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hutchison-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>This was a study on the ability to make a cast by surgical trainees. Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Konradsen-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. The type of participants did not meet the inclusion criteria.<BR/>Described fractures of the second to fifth metacarpal. No separate data analysis was possible for the fifth metacarpal fractures.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-McMahon-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. The type of participants did not meet the inclusion criteria. Patients with metacarpal shaft fractures were included, not subcapital fractures. No specific data were given on which metacarpal was fractured.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Randall-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. The type of participants did not meet the inclusion criteria.<BR/>This study included fractures of the base, shaft and neck of the metacarpal bone. All hands had to be immobilized for at least one week.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sorensen-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>RCT. The type of participants did not meet the inclusion criteria.<BR/>Described fractures of the second to fifth metacarpal. No separate data were given on fifth metacarpal.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>MCP: metacarpal phalangeal joint<BR/>RCT: randomized controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-08-11 14:44:34 +0200" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2008-08-11 14:44:34 +0200" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="NO" STUDY_ID="STD-Anand-1999">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Braakman-1998b">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-11 14:44:13 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Harding-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-11 14:44:19 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kuokkanen-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-08-11 14:44:34 +0200" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Statius-Muller-2003">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-08-11 14:45:06 +0200" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2008-08-07 14:03:24 +0200" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-07-10 15:17:37 +0200" MODIFIED_BY="Lindsey Elstub">Quality assessment tool</TITLE>
<TABLE COLS="2" ROWS="12">
<TR>
<TH VALIGN="TOP">
<P>
<B>Items</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Scores</B>
</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>A. Was the assigned treatment adequately concealed prior to allocation?</P>
</TD>
<TD VALIGN="TOP">
<P>2 = (Cochrane code A) yes; method did not allow disclosure of assignment<BR/>1 = (Cochrane code B) not sure; small but possible chance of disclosure of assignment or unclear<BR/>0 = (Cochrane code C) clearly no; quasi-randomized or open list/tables</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>B. Were the outcomes of participants who withdrew described and included in the analysis (intention-to-treat)?</P>
</TD>
<TD VALIGN="TOP">
<P>2 = intention-to-treat analysis based on all cases randomized possible or carried out<BR/>1 = states number and reasons for withdrawal but intention-to-treat analysis not possible<BR/>0 = not mentioned, or states number of withdrawals only</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>C. Were the outcome assessors blinded to treatment status?</P>
</TD>
<TD VALIGN="TOP">
<P>2 = effective action taken to blind assessors<BR/>1 = small or moderate chance of unblinding of assessors<BR/>0 = not mentioned or not possible</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>D. Were the treatment and control group comparable at entry?</P>
</TD>
<TD VALIGN="TOP">
<P>2 = good comparability of groups, or confounding adjusted for in analysis<BR/>1 = confounding small; mentioned but not adjusted for<BR/>0 = large potential for confounding, or not discussed</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>E. Were the treatment providers blind to assignment status?</P>
</TD>
<TD VALIGN="TOP">
<P>2 = effective action taken to blind treatment providers<BR/>1 = small or moderate chance of unblinding of treatment providers<BR/>0 = not possible, or not mentioned (unless double blind), or possible but not done</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>F. Were care programmes, other than the trial options, identical?</P>
</TD>
<TD VALIGN="TOP">
<P>2 = care programmes clearly identical<BR/>1 = clear but trivial differences<BR/>0 = not mentioned or clear and important differences in care programmes</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>G. Were the inclusion and exclusion criteria clearly defined?</P>
</TD>
<TD VALIGN="TOP">
<P>2 = clearly defined<BR/>1 = inadequately defined<BR/>0 = not defined</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>H. Were the interventions clearly defined?</P>
</TD>
<TD VALIGN="TOP">
<P>2 = clearly defined interventions are applied with a standardized protocol<BR/>1 = clearly defined interventions are applied but the application protocol is not standardized<BR/>0 = intervention and/or application protocol are poorly or not defined</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>I. Were the outcome measures used clearly defined?</P>
</TD>
<TD VALIGN="TOP">
<P>2 = clearly defined<BR/>1 = inadequately defined<BR/>0 = not defined</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>J. Were diagnostic tests used in outcome assessment clinically useful? (by outcome)</P>
</TD>
<TD VALIGN="TOP">
<P>2 = optimal<BR/>1 = adequate<BR/>0 = not defined, not adequate</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>K. Was the surveillance active, and of clinically appropriate duration?</P>
</TD>
<TD VALIGN="TOP">
<P>2 = active surveillance and appropriate duration (set visits up to six months or longer)<BR/>1 = active surveillance, but inadequate duration (set visits for three months)<BR/>0 = surveillance not active or not defined (no set visits or time of follow up not detailed).</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2008-07-14 20:25:05 +0200" MODIFIED_BY="Lindsey Elstub" NO="2">
<TITLE>Numbers of patients analyzed in each group</TITLE>
<TABLE COLS="6" ROWS="11">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Anand 1999</P>
</TH>
<TH>
<P>Braakman 1998b</P>
</TH>
<TH>
<P>Harding 2001</P>
</TH>
<TH>
<P>Kuokkanen 1999</P>
</TH>
<TH>
<P>Statius Muller 2003</P>
</TH>
</TR>
<TR>
<TD>
<P>Number meeting inclusion criteria</P>
</TD>
<TD>
<P>60</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD>
<P>73</P>
</TD>
<TD>
<P>29</P>
</TD>
<TD>
<P>40</P>
</TD>
</TR>
<TR>
<TD>
<P>Excluded before randomization</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Number randomized in control group</P>
</TD>
<TD>
<P>28</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD>
<P>42</P>
</TD>
<TD>
<P>15</P>
</TD>
<TD>
<P>20</P>
</TD>
</TR>
<TR>
<TD>
<P>Post randomization exclusion in control group</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Number analyzed in control group</P>
</TD>
<TD>
<P>28</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD>
<P>37</P>
</TD>
<TD>
<P>15</P>
</TD>
<TD>
<P>15</P>
</TD>
</TR>
<TR>
<TD>
<P>Number of dropouts in control group</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>5</P>
</TD>
</TR>
<TR>
<TD>
<P>Number randomized in first treatment group</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD>
<P>25</P>
</TD>
<TD>
<P>31</P>
</TD>
<TD>
<P>14</P>
</TD>
<TD>
<P>20</P>
</TD>
</TR>
<TR>
<TD>
<P>Post randomization exclusion in first treatment group</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>Number analyzed in first treatment group</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD>
<P>23</P>
</TD>
<TD>
<P>28</P>
</TD>
<TD>
<P>14</P>
</TD>
<TD>
<P>20</P>
</TD>
</TR>
<TR>
<TD>
<P>Number of dropouts in first treatment group</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>nd: not described</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2008-07-10 15:17:49 +0200" MODIFIED_BY="Lindsey Elstub" NO="3">
<TITLE>Cross tabulation of interventions</TITLE>
<TABLE COLS="7" ROWS="8">
<TR>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Splinting with plaster of Paris with immobilization of both the MCP and wrist joint</P>
</TD>
<TD>
<P>Functional bracing with free movement in both the MCP and wrist joint</P>
</TD>
<TD>
<P>Functional taping with free movement in both the MCP and wrist joint</P>
</TD>
<TD>
<P>Elastic bandage with free movement in both the MCP and wrist joint</P>
</TD>
<TD>
<P>Neighbour strapping with free movement in both the MCP and wrist joint</P>
</TD>
<TD>
<P>Full dynamic treatment with no external support with free movement in both the MCP and wrist joint</P>
</TD>
</TR>
<TR>
<TD>
<P>Splinting with plaster of Paris with immobilization of both the MCP and wrist joint</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Braakman 1998b</P>
</TD>
<TD>
<P>Anand 1999<BR/>Kuokkanen 1999<BR/>Statius Muller 2003</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Functional bracing with free movement in both the MCP and wrist joint</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Harding 2001</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Functional taping with free movement in both the MCP and wrist joint</P>
</TD>
<TD>
<P>Braakman 1998b</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Elastic bandage with free movement in both the MCP and wrist joint</P>
</TD>
<TD>
<P>Anand 1999<BR/>Kuokkanen 1999<BR/>Statius Muller 2003</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Neighbour strapping with free movement in both the MCP and wrist joint</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Harding 2001</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Full dynamic treatment with no external support with free movement in both the MCP and wrist joint</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>x<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2008-08-07 14:27:37 +0200" MODIFIED_BY="[Empty name]" NO="4">
<TITLE>Results</TITLE>
<TABLE COLS="6" ROWS="11">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Treatment group</P>
</TH>
<TH>
<P>Patient satisfaction</P>
</TH>
<TH>
<P>Cosmetic appearance</P>
</TH>
<TH>
<P>Pain</P>
</TH>
<TH>
<P>Fracture angulation</P>
</TH>
</TR>
<TR>
<TD>
<P>Anand 1999</P>
</TD>
<TD>
<P>Cast</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>20 of 21 patients satisfied</P>
</TD>
<TD>
<P>None of the patients at 3 months</P>
</TD>
<TD>
<P>Dorsal angulation post Rx: 27º (5º-45º)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Compression bandage</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>28 of 28 patients satisfied</P>
</TD>
<TD>
<P>None of the patients at 3 months</P>
</TD>
<TD>
<P>Dorsal angulation post Rx: 41º (15º-80º)</P>
</TD>
</TR>
<TR>
<TD>
<P>Braakman 1998b</P>
</TD>
<TD>
<P>Cast</P>
</TD>
<TD>
<P>Number of patients with subjective residual symptoms 9 of 25.</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>Mean angulation (range): 27.4º (0º-67º)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Tape</P>
</TD>
<TD>
<P>Number of patients with subjective residual symptoms 8 of 23.</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>Mean 24.7º, range (2º-46º)</P>
</TD>
</TR>
<TR>
<TD>
<P>Harding 2001</P>
</TD>
<TD>
<P>Metacarpal brace</P>
</TD>
<TD>
<P>Overall satisfaction: fully satisfied 6, satisfied 22, dissatisfied 9.</P>
</TD>
<TD>
<P>One patient complaint about a lump at the fracture side.</P>
</TD>
<TD>
<P>Mean pain score (possible range 0-3): 0.6 (0-2)</P>
</TD>
<TD>
<P>nd</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Neighbour strapping</P>
</TD>
<TD>
<P>Overall satisfaction: fully satisfied 5, satisfied 15, dissatisfied 8.</P>
</TD>
<TD>
<P>One patient complaint about a lump at the fracture side.</P>
</TD>
<TD>
<P>Mean pain score (possible range 0-3): 1.6 (0-3)</P>
</TD>
<TD>
<P>nd</P>
</TD>
</TR>
<TR>
<TD>
<P>Kuokkanen 1999</P>
</TD>
<TD>
<P>Cast</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>Median (range) 35º (10º-55º), at 4 weeks 30º (10º-50º), at 3 months 29º (10º-50º)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Compression bandage</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>Median (range) 48º (35º-60º), at 4 weeks 42º (20º-60º), at 3 months 42º (20º-60º)</P>
</TD>
</TR>
<TR>
<TD>
<P>Statius Muller 2003</P>
</TD>
<TD>
<P>Cast</P>
</TD>
<TD>
<P>At 6 weeks fully satisfied 60%, at 12 weeks 80%.</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>At 6 weeks no pain: 87%, at 12 weeks 93%</P>
</TD>
<TD>
<P>nd</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Compression bandage</P>
</TD>
<TD>
<P>At 6 weeks fully satisfied 60%, at 12 weeks 80%.</P>
</TD>
<TD>
<P>nd</P>
</TD>
<TD>
<P>At 6 weeks no pain: 70%, at 12 weeks 95%</P>
</TD>
<TD>
<P>nd</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>nd: not described<BR/>Rx: treatment</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2008-08-07 14:11:49 +0200" MODIFIED_BY="[Empty name]" NO="5">
<TITLE>Results (continued)</TITLE>
<TABLE COLS="6" ROWS="11">
<TR>
<TH VALIGN="TOP">
<P>Study ID</P>
</TH>
<TH VALIGN="TOP">
<P>Intervention</P>
</TH>
<TH VALIGN="TOP">
<P>ROM in MCP joint</P>
</TH>
<TH VALIGN="TOP">
<P>Grip strength</P>
</TH>
<TH VALIGN="TOP">
<P>Skin damage</P>
</TH>
<TH VALIGN="TOP">
<P>Return to work</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Anand 1999</P>
</TD>
<TD VALIGN="TOP">
<P>Cast</P>
</TD>
<TD VALIGN="TOP">
<P>Extensor lag at 3 months: 5 degrees in 2 participants</P>
</TD>
<TD VALIGN="TOP">
<P>At 6 weeks: 69% of normal (17 participants)</P>
<P>At 3 months: 99% of normal (13 participants)</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
<TD VALIGN="TOP">
<P>Return to pre-injury status at 3 months: 100% (21 participants)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Compression bandage</P>
</TD>
<TD VALIGN="TOP">
<P>Extensor lag at 3 months: 5 degrees in 2 participants</P>
</TD>
<TD VALIGN="TOP">
<P>At 6 weeks: 91% of normal (24 participants)</P>
<P>At 3 months: 98% of normal (22 participants)</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
<TD VALIGN="TOP">
<P>Return to pre-injury status at 3 months: 100% (28 participants)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Braakman 1998b</P>
</TD>
<TD VALIGN="TOP">
<P>Cast</P>
</TD>
<TD VALIGN="TOP">
<P>At 1 week: extension deficit 19 participants, flexion deficit 11 participants</P>
<P>At 4 weeks: extension deficit 11 participants, flexion deficit 4 participants</P>
<P>At 3 months: extension deficit 6 participants, flexion deficit 2 participants</P>
<P>At 6 months: flexion deficit 1 participant</P>
</TD>
<TD VALIGN="TOP">
<P>The 50% recovery limit of power-grip and pulling strength was reached within four weeks in 52% of the participants.</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Tape</P>
</TD>
<TD VALIGN="TOP">
<P>At 1 week: extension deficit 8 participants, flexion deficit 2 participants</P>
<P>No extension or flexion deficit at 4 weeks, 3 and 6 months</P>
</TD>
<TD VALIGN="TOP">
<P>Restoration of pulling strength was significantly better in the tape group after one and four weeks (P&lt;0.001). The 50% recovery limit of power-grip and pulling strength was reached within four weeks in all participants.</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Harding 2001</P>
</TD>
<TD VALIGN="TOP">
<P>Metacarpal brace</P>
</TD>
<TD VALIGN="TOP">
<P>Mean (range) ROM of MCPJ: active 78 (40-130), passive 107 (70-150)</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
<TD VALIGN="TOP">
<P>One participant</P>
</TD>
<TD VALIGN="TOP">
<P>Return to work by 3 weeks: 92% (34 of 37 participants)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Neighbour strapping</P>
</TD>
<TD VALIGN="TOP">
<P>Mean (range) ROM of MCPJ: active 65 (20-90), passive 97 (40-130)</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
<TD VALIGN="TOP">
<P>None</P>
</TD>
<TD VALIGN="TOP">
<P>Return to work by 3 weeks: 29% (8 of 28 participants)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Kuokkanen 1999</P>
</TD>
<TD VALIGN="TOP">
<P>Cast</P>
</TD>
<TD VALIGN="TOP">
<P>ROM in degrees (range):</P>
<P>At 4 weeks: 57 (10-100).</P>
<P>At 3 months: 90 (80-95)</P>
</TD>
<TD VALIGN="TOP">
<P>Kg, fractured hand/healthy hand: </P>
<P>At 4 weeks: 21 (10-50)/34 (18-54)Kg.</P>
<P>At 3 months: 36 (26-54)/41 (22-59) Kg.</P>
</TD>
<TD VALIGN="TOP">
<P>None</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Compression bandage</P>
</TD>
<TD VALIGN="TOP">
<P>ROM in degrees (range):</P>
<P>At 4 weeks: 81 (45-90)</P>
<P>At 3 months: 90 (80-95)</P>
</TD>
<TD VALIGN="TOP">
<P>Kg, fractured hand/healthy hand: </P>
<P>At 4 weeks: 37 (20-54)/44 (25-72) Kg. </P>
<P>At 3 months: 49 (30-69)/51 (30-74) Kg.</P>
</TD>
<TD VALIGN="TOP">
<P>None</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Statius Muller 2003</P>
</TD>
<TD VALIGN="TOP">
<P>Cast</P>
</TD>
<TD VALIGN="TOP">
<P>Full ROM at 6 weeks: 67%</P>
<P>Full ROM at 12 weeks: 93%</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
<TD VALIGN="TOP">
<P>Return to work or hobby at 6 weeks: 2 participants</P>
<P>Return to work or hobby at 12 weeks: all participants</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Compression bandage</P>
</TD>
<TD VALIGN="TOP">
<P>Full ROM at 6 weeks: 70%</P>
<P>Full ROM 12 weeks: 95%</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
<TD VALIGN="TOP">
<P>nd</P>
</TD>
<TD VALIGN="TOP">
<P>Return to work or hobby at 6 weeks: 2 participants</P>
<P>Return to work or hobby at 12 weeks: all participants</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>MCPJ: metacarpo-phalangeal joint<BR/>nd: not described<BR/>ROM: range of motion or movement</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-06" MODIFIED="2008-08-11 14:45:06 +0200" MODIFIED_BY="[Empty name]" NO="6">
<TITLE MODIFIED="2008-08-04 13:42:00 +0200" MODIFIED_BY="Lindsey Elstub">Results: quality assessment</TITLE>
<TABLE COLS="6" ROWS="12">
<TR>
<TH>
<P/>
</TH>
<TH>
<P>Anand 1999</P>
</TH>
<TH>
<P>Braakman 1998b</P>
</TH>
<TH>
<P>Harding 2001</P>
</TH>
<TH>
<P>Kuokkanen 1999</P>
</TH>
<TH>
<P>Statius Muller 2003</P>
</TH>
</TR>
<TR>
<TD>
<P>A. Was the assigned treatment adequately concealed prior to allocation?</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>B. Were the outcomes of participants who withdrew described and included in the analysis (intention-to-treat)?</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>C. Were the outcome assessors blinded to treatment status?</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>D. Were the treatment and control group comparable at entry?</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>E. Were the treatment providers blind to assignment status?</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
</TR>
<TR>
<TD>
<P>F. Were care programmes, other than the trial options, identical?</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>G. Were the inclusion and exclusion criteria clearly defined?</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>H. Were the interventions clearly defined?</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>I. Were the outcome measures used clearly defined?</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>J. Were diagnostic tests used in outcome assessment clinically useful? (by outcome)</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>K. Was the surveillance active, and of clinically appropriate duration?</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-08-02 16:42:22 +0200" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2008-08-02 15:20:10 +0200" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Functional (taping) vs immobilization (POP splinting with immobilization of MCP and wrist joint)</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="23" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Not fully satisfied at final follow up</NAME>
<GROUP_LABEL_1>Tape</GROUP_LABEL_1>
<GROUP_LABEL_2>Cast</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours tape</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cast</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.0778262789243547" CI_START="0.4492727374925977" EFFECT_SIZE="0.966183574879227" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.31760923462713986" LOG_CI_START="-0.34748993421301305" LOG_EFFECT_SIZE="-0.014940349792936574" ORDER="12104" O_E="0.0" SE="0.39068254407068903" STUDY_ID="STD-Braakman-1998b" TOTAL_1="23" TOTAL_2="25" VAR="0.15263285024154588" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="31" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="69" TOTAL_2="75" WEIGHT="0.0" Z="0.0">
<NAME>Decreased range of motion</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours tape</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cast</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="19" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>At 1 week follow up</NAME>
<DICH_DATA CI_END="0.8350928260501325" CI_START="0.25082011609931265" EFFECT_SIZE="0.4576659038901602" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="19" LOG_CI_END="-0.07826524715029932" LOG_CI_START="-0.600637635462582" LOG_EFFECT_SIZE="-0.3394514413064406" ORDER="12105" O_E="0.0" SE="0.30684412667965993" STUDY_ID="STD-Braakman-1998b" TOTAL_1="23" TOTAL_2="25" VAR="0.0941533180778032" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="11" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>At 3 to 6 weeks follow up</NAME>
<DICH_DATA CI_END="0.75660330670492" CI_START="0.002932245344659558" EFFECT_SIZE="0.04710144927536232" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.12113176497221753" LOG_CI_START="-2.5327996945445443" LOG_EFFECT_SIZE="-1.326965729758381" ORDER="12106" O_E="0.0" SE="1.4166256797795689" STUDY_ID="STD-Braakman-1998b" TOTAL_1="23" TOTAL_2="25" VAR="2.0068283166109255" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>At final follow up</NAME>
<DICH_DATA CI_END="8.445091578238452" CI_START="0.015441068147078815" EFFECT_SIZE="0.3611111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.926604363404716" LOG_CI_START="-1.8113226603256165" LOG_EFFECT_SIZE="-0.4423591484604505" ORDER="12107" O_E="0.0" SE="1.6082718866965442" STUDY_ID="STD-Braakman-1998b" TOTAL_1="23" TOTAL_2="25" VAR="2.5865384615384617" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2008-08-02 15:20:10 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="46" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Loss of grip strength</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours tape</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cast</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="13" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-08-02 15:20:10 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>At 3 to 6 weeks follow up</NAME>
<DICH_DATA CI_END="0.6387865544889374" CI_START="0.0025202342996666566" EFFECT_SIZE="0.040123456790123455" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="13" LOG_CI_END="-0.19464423369309578" LOG_CI_START="-2.5985590821064553" LOG_EFFECT_SIZE="-1.3966016578997755" ORDER="12108" O_E="0.0" SE="1.4120714815284208" STUDY_ID="STD-Braakman-1998b" TOTAL_1="23" TOTAL_2="25" VAR="1.993945868945869" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>At final follow up</NAME>
<DICH_DATA CI_END="8.445091578238452" CI_START="0.015441068147078815" EFFECT_SIZE="0.3611111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.926604363404716" LOG_CI_START="-1.8113226603256165" LOG_EFFECT_SIZE="-0.4423591484604505" ORDER="12109" O_E="0.0" SE="1.6082718866965442" STUDY_ID="STD-Braakman-1998b" TOTAL_1="23" TOTAL_2="25" VAR="2.5865384615384617" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2008-08-02 16:41:12 +0200" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Functional (compression bandage) vs immobilization (POP splinting with immobilization of MCP and wrist joint)</NAME>
<DICH_OUTCOME CHI2="0.6333680117785059" CI_END="2.4879176372849643" CI_START="0.2271629533483615" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.75177304964539" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.39583599890273324" LOG_CI_START="-0.6436624936839526" LOG_EFFECT_SIZE="-0.12391324739060967" METHOD="MH" NO="1" P_CHI2="0.4261228204917701" P_Q="0.0" P_Z="0.640303591998957" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="36" WEIGHT="100.0" Z="0.46727437091063173">
<NAME>Not fully satisfied at final follow up (3 months)</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bandage</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cast</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.914492123016027" CI_START="0.010811585787040908" EFFECT_SIZE="0.25287356321839083" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7719174577312459" LOG_CI_START="-1.9661106013240706" LOG_EFFECT_SIZE="-0.5970965717964123" ORDER="12110" O_E="0.0" SE="1.6083312353465724" STUDY_ID="STD-Anand-1999" TOTAL_1="28" TOTAL_2="21" VAR="2.5867293625914316" WEIGHT="33.224222585924714"/>
<DICH_DATA CI_END="3.8148841482433915" CI_START="0.2621311581533772" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.5814813536820973" LOG_CI_START="-0.5814813536820973" LOG_EFFECT_SIZE="0.0" ORDER="12111" O_E="0.0" SE="0.6831300510639732" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="0.46666666666666656" WEIGHT="66.77577741407529"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="28" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>Not satisfied with cosmetic appearance</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bandage</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cast</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.914492123016027" CI_START="0.010811585787040908" EFFECT_SIZE="0.25287356321839083" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7719174577312459" LOG_CI_START="-1.9661106013240706" LOG_EFFECT_SIZE="-0.5970965717964123" ORDER="12112" O_E="0.0" SE="1.6083312353465724" STUDY_ID="STD-Anand-1999" TOTAL_1="28" TOTAL_2="21" VAR="2.5867293625914316" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2008-08-02 16:41:12 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="40" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>Pain</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bandage</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cast</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="2" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>At 3 to 6 weeks follow up</NAME>
<DICH_DATA CI_END="9.626102411811027" CI_START="0.5259137897586065" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="0.9834504778117132" LOG_CI_START="-0.27908544158898835" LOG_EFFECT_SIZE="0.3521825181113625" ORDER="12113" O_E="0.0" SE="0.7416198487095662" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="0.5499999999999999" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>At final follow up (3 months)</NAME>
<DICH_DATA CI_END="11.045979456272185" CI_START="0.050923505898845256" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0432042311712066" LOG_CI_START="-1.2930817043878065" LOG_EFFECT_SIZE="-0.12493873660829993" ORDER="12114" O_E="0.0" SE="1.37234592334926" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="1.8833333333333333" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.03916100550756782" CI_END="1.9435682001572407" CI_START="0.3662922980744407" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8437500000000001" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.28859978470604586" LOG_CI_START="-0.43617221302788306" LOG_EFFECT_SIZE="-0.0737862141609186" METHOD="MH" NO="4" P_CHI2="0.9806099562392138" P_Q="0.0" P_Z="0.6898397127492204" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="68" TOTAL_2="51" WEIGHT="200.0" Z="0.39907259872931966">
<NAME>Decreased range of motion</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bandage</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cast</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.397967435397608" CI_START="0.3377860716718588" DF="0.0" EFFECT_SIZE="0.9" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" I2="0.0" ID="CMP-002.04.01" LOG_CI_END="0.3798432810467528" LOG_CI_START="-0.47135826216810306" LOG_EFFECT_SIZE="-0.045757490560675115" NO="1" P_CHI2="1.0" P_Z="0.8331049625955863" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="15" WEIGHT="100.0" Z="0.2107210313156526">
<NAME>At 3 to 6 weeks follow up</NAME>
<DICH_DATA CI_END="2.3979674353976086" CI_START="0.3377860716718588" EFFECT_SIZE="0.9" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.3798432810467529" LOG_CI_START="-0.47135826216810306" LOG_EFFECT_SIZE="-0.045757490560675115" ORDER="12115" O_E="0.0" SE="0.5" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="0.25000000000000006" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.4953759105285473" CI_START="0.16092689724892642" DF="1.0" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" I2="0.0" ID="CMP-002.04.02" LOG_CI_END="0.543493888833986" LOG_CI_START="-0.7933713620505858" LOG_EFFECT_SIZE="-0.12493873660829993" NO="2" P_CHI2="1.0" P_Z="0.7141093590388772" STUDIES="2" TAU2="0.0" TOTAL_1="48" TOTAL_2="36" WEIGHT="100.0" Z="0.36634271683578534">
<NAME>At final follow up (3 months)</NAME>
<DICH_DATA CI_END="4.898066701628861" CI_START="0.11484122905327922" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.6900246950296312" LOG_CI_START="-0.9399021682462312" LOG_EFFECT_SIZE="-0.12493873660829993" ORDER="12116" O_E="0.0" SE="0.9574271077563381" STUDY_ID="STD-Anand-1999" TOTAL_1="28" TOTAL_2="21" VAR="0.9166666666666667" WEIGHT="66.66666666666667"/>
<DICH_DATA CI_END="11.045979456272185" CI_START="0.050923505898845256" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0432042311712066" LOG_CI_START="-1.2930817043878065" LOG_EFFECT_SIZE="-0.12493873660829993" ORDER="12117" O_E="0.0" SE="1.37234592334926" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="1.8833333333333333" WEIGHT="33.333333333333336"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="11.045979456272185" CI_START="0.050923505898845256" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="1.0432042311712066" LOG_CI_START="-1.2930817043878065" LOG_EFFECT_SIZE="-0.12493873660829993" METHOD="MH" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.8339580578869564" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="68" TOTAL_2="51" WEIGHT="100.0" Z="0.20962795717692106">
<NAME>Not returned to work at follow up</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bandage</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cast</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="11.045979456272185" CI_START="0.050923505898845256" DF="0.0" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-002.05.01" LOG_CI_END="1.0432042311712066" LOG_CI_START="-1.2930817043878065" LOG_EFFECT_SIZE="-0.12493873660829993" NO="1" P_CHI2="1.0" P_Z="0.8339580578869564" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="15" WEIGHT="100.0" Z="0.20962795717692106">
<NAME>At 3 to 6 weeks follow up</NAME>
<DICH_DATA CI_END="11.045979456272185" CI_START="0.050923505898845256" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0432042311712066" LOG_CI_START="-1.2930817043878065" LOG_EFFECT_SIZE="-0.12493873660829993" ORDER="12118" O_E="0.0" SE="1.37234592334926" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="1.8833333333333333" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="48" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>At final follow up (3 months)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="12119" O_E="0.0" SE="0.0" STUDY_ID="STD-Anand-1999" TOTAL_1="28" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="12120" O_E="0.0" SE="0.0" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Radiological non union (3 months)</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bandage</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cast</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="12121" O_E="0.0" SE="0.0" STUDY_ID="STD-Kuokkanen-1999" TOTAL_1="14" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Functional (neighbour strapping) vs functional brace (bracing with free movement in MCP and wrist joint)</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="23" EVENTS_2="31" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="28" TOTAL_2="37" WEIGHT="0.0" Z="0.0">
<NAME>Not fully satisfied at final follow up</NAME>
<GROUP_LABEL_1>Functional strapping</GROUP_LABEL_1>
<GROUP_LABEL_2>Functional brace</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours strapping</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2258663522437425" CI_START="0.784109192230591" EFFECT_SIZE="0.9804147465437788" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="31" LOG_CI_END="0.0884431246302492" LOG_CI_START="-0.10562345481405724" LOG_EFFECT_SIZE="-0.008590165091904025" ORDER="12122" O_E="0.0" SE="0.11399566941064694" STUDY_ID="STD-Harding-2001" TOTAL_1="28" TOTAL_2="37" VAR="0.012995012644381507" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="28" TOTAL_2="37" WEIGHT="0.0" Z="0.0">
<NAME>Not satisfied with cosmetic apperance</NAME>
<GROUP_LABEL_1>Functional strapping</GROUP_LABEL_1>
<GROUP_LABEL_2>Functional brace</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours strapping</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="20.220519583618135" CI_START="0.08635650840557213" EFFECT_SIZE="1.3214285714285714" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.3057923109680907" LOG_CI_START="-1.0637049255185391" LOG_EFFECT_SIZE="0.12104369272477576" ORDER="12123" O_E="0.0" SE="1.3918544059127331" STUDY_ID="STD-Harding-2001" TOTAL_1="28" TOTAL_2="37" VAR="1.9372586872586872" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="28" TOTAL_2="37" WEIGHT="0.0" Z="0.0">
<NAME>Skin damage</NAME>
<GROUP_LABEL_1>Functional strapping</GROUP_LABEL_1>
<GROUP_LABEL_2>Functional brace</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours strapping</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="12124" O_E="0.0" SE="0.0" STUDY_ID="STD-Harding-2001" TOTAL_1="28" TOTAL_2="37" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="28" TOTAL_2="37" WEIGHT="0.0" Z="0.0">
<NAME>Not returned to work at 3 weeks follow up</NAME>
<GROUP_LABEL_1>Functional strapping</GROUP_LABEL_1>
<GROUP_LABEL_2>Functional brace</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours strapping</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours brace</GRAPH_LABEL_2>
<DICH_DATA CI_END="26.724522174806854" CI_START="2.903988675379481" EFFECT_SIZE="8.80952380952381" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="3" LOG_CI_END="1.426909948915433" LOG_CI_START="0.4629949184227562" LOG_EFFECT_SIZE="0.9449524336690945" ORDER="12125" O_E="0.0" SE="0.5662084603677523" STUDY_ID="STD-Harding-2001" TOTAL_1="28" TOTAL_2="37" VAR="0.3205920205920206" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2008-08-02 16:42:22 +0200" MODIFIED_BY="[Empty name]" NO="4">
<NAME>All functional vs all immobilization treatment</NAME>
<DICH_OUTCOME CHI2="0.6881848155965515" CI_END="1.694731545530948" CI_START="0.4633803370786965" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8861745171387129" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.22910091343693798" LOG_CI_START="-0.33406239885721867" LOG_EFFECT_SIZE="-0.05248074271014037" METHOD="MH" NO="1" P_CHI2="0.7088635044329081" P_Q="0.0" P_Z="0.7148912256263787" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="71" TOTAL_2="61" WEIGHT="100.0" Z="0.3652949805084645">
<NAME>Not fully satisfied at final follow up</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Functional</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Fav. immobilization</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.914492123016027" CI_START="0.010811585787040908" EFFECT_SIZE="0.25287356321839083" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7719174577312459" LOG_CI_START="-1.9661106013240706" LOG_EFFECT_SIZE="-0.5970965717964123" ORDER="12126" O_E="0.0" SE="1.6083312353465724" STUDY_ID="STD-Anand-1999" TOTAL_1="28" TOTAL_2="21" VAR="2.5867293625914316" WEIGHT="12.397892968928925"/>
<DICH_DATA CI_END="2.0778262789243547" CI_START="0.4492727374925977" EFFECT_SIZE="0.966183574879227" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.31760923462713986" LOG_CI_START="-0.34748993421301305" LOG_EFFECT_SIZE="-0.014940349792936574" ORDER="12127" O_E="0.0" SE="0.39068254407068903" STUDY_ID="STD-Braakman-1998b" TOTAL_1="23" TOTAL_2="25" VAR="0.15263285024154588" WEIGHT="62.6841743644553"/>
<DICH_DATA CI_END="3.8148841482433915" CI_START="0.2621311581533772" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.5814813536820973" LOG_CI_START="-0.5814813536820973" LOG_EFFECT_SIZE="0.0" ORDER="12128" O_E="0.0" SE="0.6831300510639732" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="0.46666666666666656" WEIGHT="24.91793266661577"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2008-08-02 16:41:54 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="28" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>Not satisfied with cosmetic apperance</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours functional</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Fav. immobilization</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.914492123016027" CI_START="0.010811585787040908" EFFECT_SIZE="0.25287356321839083" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7719174577312459" LOG_CI_START="-1.9661106013240706" LOG_EFFECT_SIZE="-0.5970965717964123" ORDER="12129" O_E="0.0" SE="1.6083312353465724" STUDY_ID="STD-Anand-1999" TOTAL_1="28" TOTAL_2="21" VAR="2.5867293625914316" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2008-08-02 16:42:06 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="40" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>Pain</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours functional</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Fav. immobilization</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="2" I2="0.0" ID="CMP-004.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>At 3 to 6 weeks follow up</NAME>
<DICH_DATA CI_END="9.626102411811027" CI_START="0.5259137897586065" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="0.9834504778117132" LOG_CI_START="-0.27908544158898835" LOG_EFFECT_SIZE="0.3521825181113625" ORDER="12130" O_E="0.0" SE="0.7416198487095662" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="0.5499999999999999" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-004.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>At final follow up</NAME>
<DICH_DATA CI_END="11.045979456272185" CI_START="0.050923505898845256" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0432042311712066" LOG_CI_START="-1.2930817043878065" LOG_EFFECT_SIZE="-0.12493873660829993" ORDER="12131" O_E="0.0" SE="1.37234592334926" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="1.8833333333333333" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.189838433069326" CI_END="0.8734831265673314" CI_START="0.3167689326855852" CI_STUDY="95" CI_TOTAL="95" DF="5.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5260155109135105" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="39" I2="3.6578871484647286" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="-0.05874548004507733" LOG_CI_START="-0.499257418701333" LOG_EFFECT_SIZE="-0.27900144937320515" METHOD="MH" NO="4" P_CHI2="0.3931545554106538" P_Q="0.0" P_Z="0.013038536928846243" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.019986447915888054" TOTALS="SUB" TOTAL_1="137" TOTAL_2="126" WEIGHT="300.0" Z="2.4827149705591385">
<NAME>Decreased range of motion</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours functional</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Fav. immobilization</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.3091361935744859E-31" CI_END="0.8350928260501326" CI_START="0.2508201160993127" DF="0.0" EFFECT_SIZE="0.45766590389016026" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="19" I2="100.00000000000001" ID="CMP-004.04.01" LOG_CI_END="-0.07826524715029928" LOG_CI_START="-0.6006376354625819" LOG_EFFECT_SIZE="-0.33945144130644056" NO="1" P_CHI2="0.0" P_Z="0.010856839148468907" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="25" WEIGHT="100.0" Z="2.547273226329494">
<NAME>At 1 week follow up</NAME>
<DICH_DATA CI_END="0.8350928260501325" CI_START="0.25082011609931265" EFFECT_SIZE="0.4576659038901602" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="19" LOG_CI_END="-0.07826524715029932" LOG_CI_START="-0.600637635462582" LOG_EFFECT_SIZE="-0.3394514413064406" ORDER="12132" O_E="0.0" SE="0.30684412667965993" STUDY_ID="STD-Braakman-1998b" TOTAL_1="23" TOTAL_2="25" VAR="0.0941533180778032" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.771896429417345" CI_END="8.357403758993813" CI_START="0.007550934842435455" DF="1.0" EFFECT_SIZE="0.2512094967076034" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" I2="82.67467179585294" ID="CMP-004.04.02" LOG_CI_END="0.9220713841065351" LOG_CI_START="-2.1219992772743965" LOG_EFFECT_SIZE="-0.5999639465839308" NO="2" P_CHI2="0.016284482772522146" P_Z="0.4397656734906422" STUDIES="2" TAU2="5.384675492921819" TOTAL_1="43" TOTAL_2="40" WEIGHT="100.0" Z="0.7725889824078992">
<NAME>At 3 to 6 weeks follow up</NAME>
<DICH_DATA CI_END="0.75660330670492" CI_START="0.002932245344659558" EFFECT_SIZE="0.04710144927536232" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.12113176497221753" LOG_CI_START="-2.5327996945445443" LOG_EFFECT_SIZE="-1.326965729758381" ORDER="12133" O_E="0.0" SE="1.4166256797795689" STUDY_ID="STD-Braakman-1998b" TOTAL_1="23" TOTAL_2="25" VAR="2.0068283166109255" WEIGHT="11.754889646228946"/>
<DICH_DATA CI_END="2.3979674353976086" CI_START="0.3377860716718588" EFFECT_SIZE="0.9" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.3798432810467529" LOG_CI_START="-0.47135826216810306" LOG_EFFECT_SIZE="-0.045757490560675115" ORDER="12134" O_E="0.0" SE="0.5" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="0.25000000000000006" WEIGHT="88.24511035377105"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.16811110197559567" CI_END="2.5976242611354277" CI_START="0.16343511290876125" DF="2.0" EFFECT_SIZE="0.6515696543065876" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-004.04.03" LOG_CI_END="0.41457633183446674" LOG_CI_START="-0.7866546325998509" LOG_EFFECT_SIZE="-0.18603915038269211" NO="3" P_CHI2="0.9193802148024813" P_Z="0.5437885583680018" STUDIES="3" TAU2="0.0" TOTAL_1="71" TOTAL_2="61" WEIGHT="100.0" Z="0.6070939648749709">
<NAME>At final follow up (3 to 6 months)</NAME>
<DICH_DATA CI_END="4.898066701628861" CI_START="0.11484122905327922" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.6900246950296312" LOG_CI_START="-0.9399021682462312" LOG_EFFECT_SIZE="-0.12493873660829993" ORDER="12135" O_E="0.0" SE="0.9574271077563381" STUDY_ID="STD-Anand-1999" TOTAL_1="28" TOTAL_2="21" VAR="0.9166666666666667" WEIGHT="54.01128719340662"/>
<DICH_DATA CI_END="8.445091578238452" CI_START="0.015441068147078815" EFFECT_SIZE="0.3611111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.926604363404716" LOG_CI_START="-1.8113226603256165" LOG_EFFECT_SIZE="-0.4423591484604505" ORDER="12136" O_E="0.0" SE="1.6082718866965442" STUDY_ID="STD-Braakman-1998b" TOTAL_1="23" TOTAL_2="25" VAR="2.5865384615384617" WEIGHT="19.40892265745032"/>
<DICH_DATA CI_END="11.045979456272185" CI_START="0.050923505898845256" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0432042311712066" LOG_CI_START="-1.2930817043878065" LOG_EFFECT_SIZE="-0.12493873660829993" ORDER="12137" O_E="0.0" SE="1.37234592334926" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="1.8833333333333333" WEIGHT="26.579790149143058"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-004.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2008-08-02 16:42:22 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="46" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Loss of grip strength</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours functional</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Fav. immobilization</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="13" I2="0.0" ID="CMP-004.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>At 3 to 6 weeks follow up</NAME>
<DICH_DATA CI_END="0.6387865544889374" CI_START="0.0025202342996666566" EFFECT_SIZE="0.040123456790123455" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="13" LOG_CI_END="-0.19464423369309578" LOG_CI_START="-2.5985590821064553" LOG_EFFECT_SIZE="-1.3966016578997755" ORDER="12138" O_E="0.0" SE="1.4120714815284208" STUDY_ID="STD-Braakman-1998b" TOTAL_1="23" TOTAL_2="25" VAR="1.993945868945869" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-004.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>At final follow up ( 6 months)</NAME>
<DICH_DATA CI_END="8.445091578238452" CI_START="0.015441068147078815" EFFECT_SIZE="0.3611111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.926604363404716" LOG_CI_START="-1.8113226603256165" LOG_EFFECT_SIZE="-0.4423591484604505" ORDER="12139" O_E="0.0" SE="1.6082718866965442" STUDY_ID="STD-Braakman-1998b" TOTAL_1="23" TOTAL_2="25" VAR="2.5865384615384617" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="11.045979456272185" CI_START="0.050923505898845256" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-004.06" LOG_CI_END="1.0432042311712066" LOG_CI_START="-1.2930817043878065" LOG_EFFECT_SIZE="-0.12493873660829993" METHOD="MH" NO="6" P_CHI2="1.0" P_Q="0.0" P_Z="0.8339580578869564" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="68" TOTAL_2="51" WEIGHT="100.0" Z="0.20962795717692106">
<NAME>Not returned to work at follow up</NAME>
<GROUP_LABEL_1>Functional</GROUP_LABEL_1>
<GROUP_LABEL_2>Immobilization</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours functional</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Fav. immobilization</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="11.045979456272185" CI_START="0.050923505898845256" DF="0.0" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-004.06.01" LOG_CI_END="1.0432042311712066" LOG_CI_START="-1.2930817043878065" LOG_EFFECT_SIZE="-0.12493873660829993" NO="1" P_CHI2="1.0" P_Z="0.8339580578869564" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="15" WEIGHT="100.0" Z="0.20962795717692106">
<NAME>At 3-6 weeks follow up</NAME>
<DICH_DATA CI_END="11.045979456272185" CI_START="0.050923505898845256" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0432042311712066" LOG_CI_START="-1.2930817043878065" LOG_EFFECT_SIZE="-0.12493873660829993" ORDER="12140" O_E="0.0" SE="1.37234592334926" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="1.8833333333333333" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.06.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="48" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>At final follow up</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="12141" O_E="0.0" SE="0.0" STUDY_ID="STD-Anand-1999" TOTAL_1="28" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="12142" O_E="0.0" SE="0.0" STUDY_ID="STD-Statius-Muller-2003" TOTAL_1="20" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-08-11 15:32:09 +0200" MODIFIED_BY="Lindsey Elstub">
<APPENDIX ID="APP-01" MODIFIED="2008-08-05 12:12:44 +0200" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-08-05 12:12:44 +0200" MODIFIED_BY="[Empty name]">Search strategy for MEDLINE</TITLE>
<APPENDIX_BODY MODIFIED="2008-08-05 12:11:45 +0200" MODIFIED_BY="[Empty name]">
<TABLE COLS="1" ROWS="2">
<TR>
<TH VALIGN="TOP">
<P>MEDLINE (OVID-WEB)</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1. Metacarpus/<BR/>2. boxer$ fracture$.tw.<BR/>3. little finger$.tw.<BR/>4. metacarp$.tw.<BR/>5. (fifth adj3 finger$).tw.<BR/>6. or/1-5<BR/>7. Fractures/<BR/>8. fracture$.tw.<BR/>9. or/7-8<BR/>10. and/6,9<BR/>11. randomized controlled trial.pt.<BR/>12. controlled clinical trial.pt.<BR/>13. Randomized Controlled Trials/<BR/>14. Random Allocation/<BR/>15. Double Blind Method/<BR/>16. Single Blind Method/<BR/>17. or/11-16<BR/>18. Animals/ not Humans/<BR/>19. 17 not 18<BR/>20. clinical trial.pt.<BR/>21. exp Clinical Trials/<BR/>22. (clinic$ adj25 trial$).tw<BR/>23. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).tw.<BR/>24. Placebos/<BR/>25. placebo$.tw.<BR/>26. random$.tw.<BR/>27. Research Design/<BR/>28. or/20-27<BR/>29. 28 not 18<BR/>30. 29 not 19<BR/>31. or/19,30<BR/>32. and/10,31</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2008-08-05 12:06:05 +0200" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2008-08-05 12:04:35 +0200" MODIFIED_BY="[Empty name]">Search strategy for EMBASE</TITLE>
<APPENDIX_BODY MODIFIED="2008-08-05 12:06:05 +0200" MODIFIED_BY="[Empty name]">
<TABLE COLS="1" ROWS="2">
<TR>
<TH VALIGN="TOP">
<P>EMBASE (OVID-WEB)</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1. Metacarpal Bone Fracture/<BR/>2. boxer$ fracture$.tw.<BR/>3. or/1-2<BR/>4. little finger$.tw.<BR/>5. metacarp$.tw.<BR/>6. (fifth adj3 finger$).tw.<BR/>7. or/4-6<BR/>8. Fracture/<BR/>9. fracture$.tw.<BR/>10. or/8-9<BR/>11. and/7,10<BR/>12. or/3,11<BR/>13. exp Randomized Controlled trial/<BR/>14. exp Double Blind Procedure/<BR/>15. exp Single Blind Procedure/<BR/>16. exp Crossover Procedure/<BR/>17. Controlled Study/<BR/>18. or/13-17<BR/>19. ((clinical or controlled or comparative or placebo or prospective$ or randomi#ed) adj3 (trial or study)).tw.<BR/>20. (random$ adj7 (allocat$ or allot$ or assign$ or basis$ or divid$ or order$)).tw.<BR/>21. ((singl$ or doubl$ or trebl$ or tripl$) adj7 (blind$ or mask$)).tw.<BR/>22. (cross?over$ or (cross adj1 over$)).tw.<BR/>23. ((allocat$ or allot$ or assign$ or divid$) adj3 (condition$ or experiment$ or intervention$ or treatment$ or therap$ or control$ or group$)).tw.<BR/>24. or/19-23<BR/>25. or/18,24<BR/>26. limit 25 to human<BR/>27. and/12,26</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2008-08-11 15:32:09 +0200" MODIFIED_BY="Lindsey Elstub" NO="3">
<TITLE MODIFIED="2008-08-11 15:32:04 +0200" MODIFIED_BY="Lindsey Elstub">Search strategy for <I>The Cochrane Library</I>
</TITLE>
<APPENDIX_BODY MODIFIED="2008-08-11 15:32:09 +0200" MODIFIED_BY="Lindsey Elstub">
<TABLE COLS="1" ROWS="2">
<TR>
<TH VALIGN="TOP">
<P>
<I>The Cochrane Library</I> (Wiley InterScience)</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#1 MeSH descriptor Metacarpal Bones, this term only<BR/>#2 (boxer* fracture*):ti,ab,kw<BR/>#3 (little finger*):ti,ab,kw<BR/>#4 (metacarp*):ti,ab,kw<BR/>#5 (fifth near3 finger*):ti,ab,kw<BR/>#6 (#1 OR #2 OR #3 OR #4 OR #5)<BR/>#7 MeSH descriptor Fractures, Bone explode all trees<BR/>#8 (fracture*):ti,ab,kw<BR/>#9 (#7 OR #8)<BR/>#10 (#6 AND #9)</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>